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Abstract 
The persistent environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) is a potent ovarian toxicant.  These studies were designed to characterize the 
actions of TCDD on steroidogenesis, growth, and atresia of intact mouse antral follicles 
in vitro.  Interestingly, TCDD has been shown to act mainly through binding to the aryl 
hydrocarbon receptor (AHR) in other tissues, and the AHR has been identified as an 
important factor in ovarian function.  Thus, these studies were also designed to test the 
hypothesis that TCDD activates the AHR in antral follicles.  Specifically, these studies 
were designed to test the hypothesis that TCDD exposure leads to decreased sex 
hormone production/secretion by antral follicles as well as decreased growth of antral 
follicles in vitro.   Mouse antral follicles were exposed for 96 hours to a series of TCDD 
doses previously shown to have effects on ovarian tissues and cells in culture and to 
encompass environmentally relevant and pharmacological exposures (0.1-100nM).  The 
results indicate that TCDD decreases progesterone (P), androstenedione (A4), 
testosterone (T), and estradiol (E2) levels in a dose response manner without altering 
growth of antral follicles.   
The 1nM dose of TCDD consistently lowered all four hormones measured.  Thus, 
this dose was chosen to study more closely the mechanism of TCDD toxicity in the 
antral follicle.  Interestingly, the addition of pregnenolone substrate (10μM) restores 
hormone levels to control levels, suggesting that TCDD has actions upstream of 
progesterone production.   Thus, the next goal of these studies was to determine the 
mechanism by which TCDD inhibits steroidogenesis and whether this occurs in a time 
dependent manner.  Specifically, experiments were designed to compare the effects of 
48 and 96 hours TCDD exposure on hormone production/secretion, steroidogenic 
enzymes, atresia ratings, expression of members of the apoptotic pathway, and 
expression of the AHR and cytochrome P450, family 1, subfamily b, polypeptide 1 
(Cyp1b1).  TCDD exposure for 48 hours increased levels of A4, without changing 
HSD3B1 protein, HSD17B1 protein, estrone (E1), T or E2 levels.  Further, TCDD did not 
alter atresia rating, but it did down-regulate the AHR protein compared to vehicle.  
TCDD exposure for 96 hours decreased transcript levels for Cyp11a1, Cyp17a1, 
Hsd17b1, and Cyp19a1, but increased Hsd3b1 transcript.  TCDD exposure particularly 
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lowered both Hsd17b1 transcript and HSD17B1 protein.  However, TCDD exposure did 
not affect levels of E1 in the media.  The down regulation of the AHR protein in TCDD 
exposed follicles persisted and Cyp1b1 transcripts were increased by 3-4 fold.  
Interestingly, levels of the proapototic factor, BCL2-associated X protein (Bax) were 
significantly reduced without affecting atresia ratings in antral follicles following TCDD 
exposure, suggesting an altered apoptotic pathway in exposed antral follicles.   
Finally, because Cyp1b1 is an important enzyme that is implicated in both 
biotransformation of TCDD and also in E2 catabolism to catecholestrogens and the 
highly reactive quinones, increased levels of Cyp1b1 could be an indication of a system 
under stress.  Quinones are known to cause DNA damage, and if the DNA is left 
unrepaired, it can lead to mutations that propagate into daughter cells, leading to 
cancer.  Besides its effects on E2 levels, chronic TCDD exposure causes promotion of 
ovarian tumors in rats and acute exposure is associated with an increased incidence of 
ovarian cancer in young woman.  The enzyme catechol-o-methyltransferase (COMT) is 
regulated by E2 and is an important enzyme for inactivating the catecholestrogens.  
Thus, we hypothesized that TCDD exposure affects the levels of COMT.  TCDD 
exposure reduced COMT protein levels, while there was no change in transcript levels 
for COMT after 96 hours exposure in antral follicles.  Overall, these data indicate that 
TCDD exposure perturbs steroidogenesis by impairing the steroidogenic enzymes, and 
that it alters apoptotic pathways, and potentially decreases the ability to neutralize 
reactive metabolites in antral follicles.   Finally, the activation and proteasomal 
degradation of the AHR in the antral follicle likely plays a central role in these 
processes, contributing to endocrine disruption, cancer promotion, and ovarian toxicity 
by TCDD. 
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Chapter I: Introduction  
 
Introduction 
 
1.1 Functioning of the hypothalamus pituitary ovarian axis (HPOA) 
 
Functioning of the female reproductive system is absolutely dependent on a tightly 
regulated feedback system conducted by the hypothalamus-pituitary-ovarian-axis 
(HPOA) (Freeman 2006).  During adulthood, the hypothalamus, also known as the 
“central relay station”, collects and integrates signals from the ovary and the 
environment, and relays them to the anterior pituitary gland.  Specifically, the 
hypothalamus synthesizes and releases gonadotropin-releasing hormone (GnRH) from 
neurons in the medial preoptic, anterior hypothalamic areas, and arcuate nucleus 
through the hypophysial portal system to the anterior pituitary gland. GnRH stimulates 
the anterior pituitary to synthesize and release follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) from the gonadotrophs.  FSH binds to receptors on ovarian 
follicles and stimulates follicle growth and estrogen (E2) production.  LH also binds to 
receptors on ovarian cells and can stimulate ovulation.  Ovarian steroids produced in 
response to pituitary hormones can feedback to the hypothalamus and anterior pituitary 
and suppress GnRH, FSH, and LH release via negative feedback (Neill et al. 2006).  
The ovarian produced sex steroid hormones (i.e., estrogens, progestins, and 
androgens) are also responsible for regulating the supporting organs of the female 
reproductive system such as the oviduct, uterus and vagina that are vital for successful 
fertilization, implantation and pregnancy (Johnson et al. 1995). 
The follicle is the main functional unit of the ovary.  Proper functioning of the ovary 
during adult life relies on recruitment of cohorts of primordial follicles into the growing 
pool.  There are two broad categories of follicle recruitment in the ovary: initial activation 
of primordial follicles from the resting pool, which occurs throughout the female lifespan 
until reproductive senescence; and, cyclic recruitment of a limited number of small 
follicles for ovulation from the growing cohort, which only occurs after puberty (Edson et 
al., 2009; McGee and Hsueh 2000).  A follicle must go through several developmental 
stages in a process called folliculogenesis before it is capable of ovulation.  
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Folliculogenesis is a complex physiological process that relies on autocrine, paracrine, 
juxtacrine, and endocrine factors (Edson et al., 2009).   
The major stages of folliculogenesis can be classified into several categories.  The 
names commonly used to describe these follicle stages are primordial, primary, 
preantral, antral, and pre-ovulatory (Pedersen and Peters 1968).  During transition from 
the primordial to primary follicle, the morphological appearance of the granulosa cells 
surrounding the oocyte changes from squamous to cuboidal, and the oocyte increases 
in size (Hirshfield 1991; Makabe et al., 2006).  Primary follicles then can grow into 
preantral follicles.  During this process, the granulosa cells proliferate, producing 
multiple layers of granulosa cells surrounding the oocyte.  In addition, the oocyte 
secretes proteins that form the zona pellucida.  Stromal cells begin to condense around 
the outer basement membrane to form additional layers of spindle shaped cells called 
the theca cells.  The theca cells develop into two distinct layers, an inner highly vascular 
theca interna and a fibrous theca externa.  Intercellular communication between the 
different follicle cell types is partly maintained through gap junctions (Eppig 2001; Kidder 
and Mhawi 2002).  Once follicles develop a theca layer, they are capable of producing 
E2.   
The process of sex steroid hormone synthesis in the rodent antral follicle (see 
diagram 1.6) begins in the thecal cells and involves mobilization of cholesterol into the 
inner mitochondrial membrane via steroidogenic acute regulatory protein (STAR) where 
it is cleaved by the enzyme CYP11A1 to pregnenolone (P5).  The thecal smooth 
endoplasmic reticulum is the site for hydroxy-delta-5-steroid dehydrogenase, 3 beta- 
and steroid delta-isomerase 1 (HSD3B1) isozyme conversion of P5 to progesterone 
(P4) and dehydroepiandrosterone (DHEA) to androstenedione (A4); and for the 
conversion of P5 to DHEA under cytochrome P450, family 17, subfamily a, polypeptide 
1 (CYP17A1).  A4 then diffuses across the basement membrane to the granulosa cells 
where it is either aromatized by cytochrome P450, family 19, subfamily a, polypeptide 1 
(CYP19A1) to estrone (E1) and converted via hydroxysteroid (17-beta) dehydrogenase 
1 (HSD17B1) to estradiol-17β (E2), or metabolized to testosterone (T) via HSD17B1.  T 
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is then aromatized to E2 by CYP19A1 (for a more detailed review of ovarian 
steroidogenesis, see (Edson et al., 2009).  
As the follicle continues to grow, fluid begins to accumulate between the 
proliferating granulosa cells, ultimately forming an antral space.  Once the follicle 
obtains an antral space, it is called an antral follicle and has entered the gonadotropin-
dependent growth phase.  Starting from this phase, follicle differentiation and growth are 
partly under the control of the pituitary gonadotropin hormones LH and FSH.  LH 
stimulates the synthesis of androgens by binding to LH receptors (LHCGR) on the 
thecal cells and FSH stimulates the conversion of androgens to E2 by binding to follicle 
stimulating hormone receptors (FSHR) on the granulosa cells.  The E2 produced by the 
follicles promotes granulosa cell proliferation and follicle growth (Jamnongjit and 
Hammes 2006).  As the volume of the follicular fluid increases, the antral space 
expands, subsequently increasing the size of the follicle.  During the later stages of 
antral follicle growth, the oocyte becomes suspended in the antral fluid and is 
surrounded by a layer of granulosa cells called the cumulus oophorus.  Only follicles at 
this stage of development are called pre-ovulatory and are capable of ovulation (Edson 
et al., 2009).  
During ovulation, the follicle ruptures and releases the ooctye for fertilization.  
The remaining somatic cells form the corpus luteum (CL).  The cells of the CL become 
specialized and their primary role is to produce progesterone, which is critical for 
maintenance of early pregnancy.  In the absence of pregnancy hormones, the CL 
regresses in a luteolytic process leading to a drop in progesterone levels, a process 
necessary for maintaining reproductive cyclicity (Stouffer 2006).  
In the mouse, ovulation occurs approximately every 4-5 days (Champlin et al., 
1973).  Only a few follicles grow from the primordial to the preovulatory stage and 
release an oocyte during ovulation.  Most follicles (>95%) reach the pre-antral/antral 
stage and undergo atresia via programmed cell death (Hirshfield 1991; Gosden and 
Spears 1997).  Female infertility can be the result of problems in follicle pool 
maintenance, follicle recruitment, follicle growth, follicle atresia, steroidogenesis, and 
ovulation (Edson et al., 2009; Hoyer 2005; Matzuk and Lamb 2008).  
4 
 
1.2 The endocrine disruptor: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
In recent years a number of environmental toxicants have been identified that 
directly interfere with ovarian function and contribute to female infertility.  TCDD is 
considered a potent ovarian toxicant.  TCDD is a persistent environmental contaminant 
inadvertently produced as a by-product of herbicide and pesticide manufacturing (Hites 
2011).  TCDD is also released during the bleaching process at tree pulp and paper 
mills, and during the burning of municipal solid waste (Frakes et al., 1993; Tuppurainen 
et al., 2003).  TCDD is the most toxic member of a class of chemicals called dioxins.  
Dioxins, like TCDD, have a long environmental half-life, bioaccumulate in the food 
chain, and can be found in human fat tissue, blood serum, breast milk and ovarian 
follicular fluid (Birnbaum and DeVito 1995; Humblet et al., 2011; Schecter et al., 2006; 
Tsutsumi et al., 2011; Ulaszewska et al., 2011).  TCDD has a long half-life in the body 
and can remain for more than 10 years in humans after a single exposure due to its 
highly lipophilic nature, slow metabolism, and slow excretion (Miniero et al., 2001; Sorg 
et al., 2009).     
Studies of human populations accidentally exposed to high levels of TCDD and 
controlled studies using various animal models exposed to TCDD have shown that 
TCDD is a potent endocrine disruptor.  TCDD exposures have been linked to delayed 
puberty and early onset of menopause in women, as well as an increased incidence of 
ovarian cancer in young woman (Eskenazi et al., 2005; Pesatori et al., 1993; Warner et 
al., 2007).  Similarly, TCDD exposures lead to early puberty, irregular estrous cycles, 
reduced or blocked ovulation, decreased circulating estradiol levels (E2), early 
reproductive senescence, and promotion of ovarian cancer in female rodents (Chaffin et 
al., 1996; Davis et al., 2000; Franczak et al., 2006; Gray and Ostby 1995; Jablonska et 
al., 2010; Li et al., 1995a; Myllymäki et al., 2005; Shi et al., 2007). 
  Though it has been shown that TCDD can affect the development and 
functioning of the rat hypothalamus and pituitary, there is convincing evidence that it 
has direct effects on the ovary as well (Cao et al., 2011; Gao et al., 2001; Mizuyachi et 
al., 2002; Petroff et al., 2001; Petroff et al., 2003).  Further, it has been demonstrated 
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that TCDD can accumulate in ovarian follicles following controlled dosing experiments in 
animals and in culture (Baldridge and Hutz 2007; Grochowalski et al., 2001).   
 
1.3 Mechanisms of TCDD toxicity 
It has been proposed that TCDD primarily acts through the aryl hydrocarbon 
receptor (AHR) to elicit toxicity.  TCDD is the most potent ligand and agonist of the 
protein transcription factor, the AHR (Okey 2007).  When the AHR is not bound to ligand 
such as TCDD, it is primarily located in the cytoplasm of the cell where it associates 
with various heat shock proteins (Gu et al., 2000; Pocar et al., 2005; Whitlock 1999).  
When it is bound to TCDD, it goes through a conformational change which allows it to 
enter the nucleus.  Once in the nucleus, it can bind to proteins such as the aryl 
hydrocarbon receptor nuclear tanslocator (ARNT) and act as a transcription factor by 
binding to various regulatory elements within the promoters of responsive genes such 
as cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1) and cytochrome 
P450, family 1, subfamily b, polypeptide 1 (Cyp1b1), which are responsible for 
biotransformation of TCDD and E2 catabolism (Badawi et al., 2001; Bhattacharyya et 
al., 1995; Otto et al., 1992).  Reactive metabolites of both TCDD and E2 can cause 
DNA damage.  
Besides its actions on the promoter activities of genes responsible for 
biotransformation, when the AHR is activated by ligands such as TCDD, it has been 
shown to bind to AHR response elements (AHREs) within the promoters of genes 
known to regulate cell differentiation, proliferation and apoptosis  (Carlson and Perdew 
2002; Safe et al., 1998; Beischlag et al., 2008; Matikainen et al., 2001).  More 
specifically, the AHR targets the promoters of estrogen responsive genes responsible 
for cell proliferation such as cathepsin D, c-fos, and pS2 (Beischlag et al., 2008; Pocar 
et al., 2005).  In fact, a functional inhibitory AHRE is located in the promoter of the 
cathepsin D gene to inhibit its transcription in human breast cancer cells (Safe and 
Krishnan 1995; Wang et al., 2000).  Furthermore, one study found a functional AHRE 
within the promoter of the proapoptotic gene Bax, and TCDD induces this gene through 
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the AHR in thymocytes (Kamath et al., 1997; Matikainen et al., 2001; Worner and 
Schrenk 1996).  Also, one study demonstrated that TCDD may act through the AHR to 
regulate the promoter activity of a rate limiting factor in steroid hormone production, 
STAR (Sugawara et al., 2001).  Additionally, there is evidence that the ligand activated 
AHR can elicit toxic effects through a nongenomic pathway that mediates inflammation, 
indicating that there is more than one mode of signaling (Matsumura 2009).  
Several mechanisms for down regulating activity and levels of the AHR following 
TCDD ligand binding have been identified.  One mechanism for down regulating the 
transcriptional activity of the AHR is through negative feedback by the aryl hydrocarbon 
receptor repressor (AHRR).  The AHRR is induced by TCDD and the AHRR competes 
with the AHR for binding to ARNT, thus inhibiting the ability of the AHR to dimerize and 
bind to AHREs within the promoters of responsive genes (Harper et al., 2006).  Another 
mechanism that regulates AHR levels is through proteolytic degradation of the AHR 
protein following TCDD ligand binding (Pollenz et al., 2005).  It has been suggested that 
the subsequent reduction in AHR protein levels following TCDD exposure attenuates 
AHR-mediated gene regulation.  Both of these mechanisms are likely an adaptive 
response to dampen TCDD toxicity in the cell through inhibiting over-expression of 
particular genes.   
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1.4  Physiology and history of the AHR 
 
 
Since its recent discovery just over 35 years ago, the AHR has received immense 
interest from the scientific community (Okey 2007; Poland et al., 1976).  Currently, there 
are well over 5000 biomedical manuscripts and abstracts cited on the topic of the AHR 
in the U.S. National Center for Biotechnology Information database, with 550 published 
just last year.  The receptor was identified by Poland et al. in 1976 during radioligand 
studies (Poland et al., 1976).  The studies were conducted to understand how 
environmental contaminants called polycyclic aromatic hydrocarbons (PAHs) could 
induce their own metabolism.  It was discovered that the PAH, TCDD, bound with high 
affinity to an endogenous receptor that was named the AHR (Poland et al., 1976).  
Isolation, purification, and cDNA cloning of the AHR during the late 1980s and early 
1990s finally revealed its protein structure and led to rapid advances in its 
characterization (Okey 2007).  These studies showed that the AHR belongs to a 
subgroup of PAS domain containing proteins within the broader basic helix-loop-helix 
(bHLH) superfamily of transcription regulators (Burbach et al., 1992; Ema et al., 1992; 
Sogawa and Fujii-Kuriyama 1997).  The PAS domain was named after the first three 
proteins identified in this subgroup, period (PER), aryl hydrocarbon receptor nuclear 
translocator (ARNT) and single minded (SIM) (Carlson and Perdew 2002;Okey 2007).  
Importantly, it was found that the bHLH/PAS proteins must dimerize via their PAS 
domain to bind to DNA via a bHLH domain (Kewley et al., 2004).  Interestingly, the 
bHLH/PAS superfamily includes members with diverse functions in development and 
environmental sensing such as the hypoxia-inducible factor 1 (Hif1a) responsible in 
oxygen sensing and clock proteins such as the aryl hydrocarbon receptor nuclear 
translocator-like (Arntl) involved in circadian rhythms (Furness et al., 2007). 
Interestingly, the AHR is the only member of this gene family with a ligand binding 
domain.  However, the AHR is still considered an orphan receptor because none of the 
physiological endogenous ligands identified so far bind to the receptor with high affinity 
(Nguyen and Bradfield 2008) 
 Beyond its role in mediating toxicity induced by environmental chemicals, more 
recent studies strongly implicate the AHR in normal physiology (Harper et al., 2006; 
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Hernández-Ochoa et al., 2009; Pocar et al., 2005).  Firstly, the receptor is ubiquitous 
and is present in all tissues examined (Okey 2007).  Varying levels of the AHR can be 
detected in multiple cell types including those in the hepatic, vascular, immune and 
reproductive systems, with highest expression in the lung and in developing fetuses 
(Carver et al., 1994; Hayashi et al., 1994; Okey 2007; Petersen et al., 2006).  Notably, 
the AHR is found in all cell types in the ovary, with  highest expression in the granulosa 
cells of follicles  (Baldridge and Hutz 2007; Robles et al., 2000; Sakurada et al., 2011).  
It is also highly conserved across animal species including rodents, fish, non-human 
primates, and humans (Okey 2007).   
Multiple cellular factors and processes have been identified that alter AHR levels 
and activity in various tissues (Harper et al., 2006).  More specifically, the AHR is 
regulated by both exogenous and endogenous hormones in the female reproductive 
tract (Chaffin et al., 2000; Khorram et al., 2002).  One study found changes in the 
expression pattern of the AHR protein in the rabbit uterus during pregnancy, indicating 
control by endogenous maternal steroid hormones (Hasan and Fischer 2003). Also, 
post-menopausal women taking hormone replacement therapy had higher levels of the 
AHR mRNA in their endometrium compared to post-menopausal women not taking 
hormone replacement therapy (Khorram et al., 2002).  
There is experimental evidence that besides being regulated by hormones and 
acting as a transcription factor through binding to AHREs, the AHR itself also directly 
interacts with other protein complexes to regulate cell cycle and steroid hormone 
receptor signaling (Barhoover et al., 2009; Ohtake et al., 2008).  One study 
demonstrated that the AHR forms a protein complex with cyclin-dependent kinase 4 
(CDK4) and cyclin D1 (CCND1) in the absence of exogenous ligands and facilitates cell 
cycle progression in human breast cancer cells (Barhoover et al., 2009).  Another study 
reported that the AHR can affect sex steroid hormone actions by assembling both a 
transcriptional co-regulator complex and a ubiquitin ligase complex with both the 
unliganded estrogen receptor 1 (ESR1) and androgen receptor (AR) (Ohtake et al., 
2008).   
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1.5 The AHR is an endogenous factor in ovarian function 
The AHR has been identified as an important factor that mediates 
steroidogenesis and hormone signaling in the ovary.  Levels of the AHR change in the 
ovary with the reproductive cycle, and FSH and E2 are modulators of AHR expression 
(Bussmann and Baranao 2006; Chaffin et al., 1999; Chaffin et al., 2000).  Furthermore, 
it has been suggested that LH may be a regulator of AHR transcriptional activity in the 
ovary by inducing the aryl hydrocarbon receptor repressor (AHRR) (Baba et al., 2005).  
This is further evidenced by increased levels of Cyp1a1 in bovine oocytes following in 
vitro maturation (Nestler et al., 2007; Pocar et al., 2004).  This rise in Cyp1a1 is blocked 
in the presence of follicular fluid, suggesting that follicular fluid may contain an 
endogenous AHR ligand or another factor that interacts with the receptor. 
Finally, the most convincing evidence for an endogenous role of the AHR in the 
ovary comes from studies using AHR -/- mice.  In the absence of the AHR, circulating 
and antral follicle produced E2 levels are reduced and ovulation is impaired (Baba et al., 
2005; Barnett et al., 2007b; Barnett et al., 2007a).  The reduced E2 levels and fewer 
ovulations are partly due to AHR regulation of the steroidogenic enzymes, estrogen 
signaling and gonadotropin responsiveness.  Specifically, it was demonstrated that the 
AHR is necessary for expression of the Cyp19a1 gene through binding to an AHRE in 
the ovary specific CYP19A1 promoter (Baba et al., 2005).  Also, AHR -/- antral follicles 
have lower levels of the estrogen receptors and gonadotropin receptors (Barnett et al., 
2007a; Barnett et al., 2007b).  It was also demonstrated that the AHR possibly regulates 
the promoter activities of the follicle hormone receptor (Fshr), but not the promoter 
activities of the luteinizing hormone receptor (Lhcgr) (Barnett et al., 2007a; Teino et al., 
2011).  Finally, it has been proposed that the AHR is not required for apoptosis in the 
ovary since AHR -/- mice do not have increased apoptosis in their ovaries when 
compared to WT mice (Benedict et al., 2003). 
Interestingly, animals and ovarian cells exposed to TCDD express a similar 
phenotype compared to the AHR -/- mice, with reduced steroidogenesis, reduced 
estrogen responsiveness, and reduced gonadotropin responsiveness (Chaffin et al., 
1996; Dasmahapatra et al., 2000; Franczak et al., 2006; Gray and Ostby 1995; 
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Hirakawa et al., 2000; Hirakawa et al., 2008; Jablonska et al., 2010; Li et al., 1995b; 
Myllymäki et al., 2005; Shi et al., 2007; Tian et al., 1998a; Tian et al., 1998b).  Also, it 
has been demonstrated that ovaries from rats exposed gestationally to TCDD do not 
have increased apoptosis while human lutenized granulosa cells exposed to TCDD in 
vitro have increased apoptosis (Heimler et al., 1998a; Heimler et al., 1998b).  Finally, it 
has been suggested that TCDD accumulation in pig ovarian follicles is associated with 
decreased proliferation of granulosa cells (Grochowalski et al., 2000). 
To date, the majority of studies aimed at unraveling the mechanism of TCDD’s 
actions on steroidogenesis, proliferation, and apoptosis utilized isolated ovarian cells in 
culture.  Although the investigation of isolated ovarian cells has been a key to better 
understanding the mechanisms of TCDD toxicity in the ovary, isolated cells lack 
connections between the thecal and granulosa follicular cell types and are missing the 
oocyte compartment of the follicle necessary for proper functioning (Matzuk et al., 
2002).  To our knowledge, studies have not reported the direct effects of TCDD on 
mouse antral follicles in vitro.  In fact, only one published study has reported on direct 
effects of TCDD on steroidogenesis and growth in follicles isolated from cycling animals 
in vitro and this study was conducted using pig follicles (Grochowalski  et al., 2000).  
The follicle culture system I used in this dissertation work has been well characterized 
and has been proven to be an excellent model for in vitro testing of ovarian function in 
reproductive toxicology studies (Cortvrindt and Smitz 2002; Gupta et al., 2006).  The 
cultured follicles maintain much of their steroidogenic and proliferative capacity 
throughout the 96 hour culture period; maintaining the presence of granulosa cells, 
theca cells, a basement membrane and oocytes in meiotic arrest (Cortvrindt et al., 
1997). Thus, unlike studies utilizing primary granulosa cells or human luteinized 
granulosa cells in culture, all the functional compartments of the follicle are present in 
our system.   
Thus in this dissertation, I used an intact mouse antral follicle culture model to test 
the hypothesis that TCDD affects steroid hormone production/secretion in mouse antral 
follicles in a dose response and time dependent manner, and that this response is due 
to impaired follicle growth, altered regulation of the steroidogenic enzymes, an 
11 
 
increased production of reactive metabolites through altered regulation of metabolizing 
enzymes, and/or altered apoptosis through regulation of apoptotic genes.  Finally, I 
tested the hypothesis that these effects are primarily through the AHR.  In chapter 2, I 
discuss the effects of TCDD on follicle growth and steroidogenesis.  In chapter 3, I 
describe the effects of TCDD on sex hormone metabolizing enzymes.  In chapter 4, I 
describe the effects of TCDD on apoptotic genes.  In chapters 2-4, I describe whether 
TCDD is exerting its various effects on follicles through the AHR.     
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Chapter II 
2,3,7,8-Tetrachlorodibenzo-p-dioxin activates the aryl hydrocarbon receptor and alters 
sex steroid hormone secretion without affecting growth of mouse antral follicles in vitro 
Previously published in http://www.journals.elsevier.com/toxicology-and-applied-pharmacology/ 
2.1 Abstract 
The persistent environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
is an ovarian toxicant.  These studies were designed to characterize the actions of 
TCDD on steroidogenesis and growth of intact mouse antral follicles in vitro.  
Specifically, these studies tested the hypothesis that TCDD exposure leads to 
decreased sex hormone production/secretion by antral follicles as well as decreased 
growth of antral follicles in vitro.  Since TCDD acts through binding to the aryl 
hydrocarbon receptor (AHR), and the AHR has been identified as an important factor in 
ovarian function, we also conducted experiments to confirm the presence and activation 
of the AHR in our tissue culture system.  To do so, we exposed mouse antral follicles for 
96 hours to a series of TCDD doses previously shown to have effects on ovarian tissues 
and cells in culture, which also encompass environmentally relevant and 
pharmacological exposures (0.1-100nM), to determine a dose response for TCDD in our 
culture system for growth, hormone production, expression of the Ahr and Cyp1b1.  The 
results indicate that TCDD decreases progesterone, androstenedione, testosterone, 
and estradiol levels in a non-monotonic dose response manner without altering growth 
of antral follicles.  The addition of pregnenolone substrate (10μM) restores hormone 
levels to control levels.  Additionally, Cyp1b1 levels were increased by 3-4 fold 
regardless of the dose of TCDD exposure, evidence of AHR activation.  Overall, these 
data indicate that TCDD may act prior to pregnenolone formation and through AHR 
transcriptional control of Cyp1b1, leading to decreased hormone levels without affecting 
growth of antral follicles.    
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2.2 Introduction 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental 
contaminant inadvertently produced as a by-product of herbicide and pesticide 
manufacturing (Hites, 2011).  TCDD is also released during the bleaching process at 
tree pulp and paper mills, and during the burning of municipal solid waste (Frakes et al., 
1993; Tuppurainen et al., 2003).  TCDD is the most toxic member of a class of 
chemicals called dioxins.  Dioxins, like TCDD, have a long environmental half-life, 
bioaccumulate in the food chain, and can be found in human fat tissue, blood serum, 
breast milk and ovarian follicular fluid (Birnbaum and DeVito, 1995; Humblet et al., 
2011; Schecter et al., 2006;Tsutsumi et al., 2011; Ulaszewska et al., 2011).   
Studies of human populations accidentally exposed to high levels of TCDD and 
controlled studies using various animal models exposed to TCDD have shown that 
TCDD is a potent endocrine disruptor.  TCDD exposures have been linked to delayed 
puberty and early onset of menopause in women (Eskenazi et al., 2005; Warner et al., 
2007).  Similarly, TCDD exposures lead to early puberty, irregular estrous cycles, 
reduced or blocked ovulation, decreased circulating estradiol levels (E2), and early 
reproductive senescence in female rodents (Gray and Ostby, 1995; Li et al., 1995 
Chaffin et al., 1996; Franczak et al., 2006; Jablonska et al., 2010; Myllymäki et al., 
2005; Shi et al., 2007). 
  Though it has been shown that TCDD can affect the development and 
functioning of the rat hypothalamus and pituitary, there is convincing evidence that it 
has direct effects on the ovary as well (Cao et al., 2011; Gao et al., 2001; Mizuyachi et 
al., 2002; Petroff et al., 2001; Petroff et al., 2003).  Further, it has been demonstrated 
that TCDD can accumulate in ovarian follicles following controlled dosing experiments in 
animals and in culture (Baldridge and Hutz, 2007; Grochowalski et al., 2001).   
Antral follicles are the main functional unit of the ovary, housing the gametes and 
serving as the primary source of sex steroid hormones, such as 17β-estradiol (E2).  
Follicles grow from the primordial to the antral stage in a process called folliculogenesis.  
In the process of folliculogenesis, follicles increase in size mainly due to proliferation of 
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granulosa cells.  It has been proposed that TCDD decreases circulating E2 levels in part 
by inhibiting the growth of follicles from the preantral to antral stage and by disrupting 
the synthesis and metabolism of sex steroid hormones (Dasmahapatra et al., 2000; 
Gregoraszczuk et al., 2001; Grochowalski et al., 2001; Heimler et al., 1998b; Heimler et 
al., 1998a; Morán et al., 2003a; Morán et al., 2000; Morán et al., 2003b; Myllymäki et 
al., 2005; Pesonen et al., 2006).  In the ovary, E2 synthesis requires both the thecal and 
granulosa cell compartments.  In the rodent, the thecal cells are responsible for 
producing progesterone (P4) and androstenedione (A4).  A4 then diffuses to nearby 
granulosa cells where it is converted to testosterone (T) and E2.  In antral follicles, the 
rate limiting steps in steroid hormone production are the mobilization of cholesterol from 
the cytoplasm to the inner mitochondrial membrane via steroidogenic acute regulatory 
protein (StAR) and the conversion of cholesterol to pregnenolone by the mitochondrial 
enzyme cytochrome P450, family 11, subfamily a, polypeptide 1 (P450scc) (Edson et 
al., 2009).  Pregnenolone is then converted to P4, and then by a multistep process to 
the androgens, and finally to E2.     
To date, the majority of studies conducted with the purpose of understanding the 
mechanism underlying disrupted follicle growth and female sex steroid hormone 
production have been conducted using isolated granulosa or thecal cells in vitro.  
Additionally, the results reported vary widely and sometimes are conflicting depending 
on the cell line, culture system, animal model, dose of TCDD, length of exposure, and 
age of the animals being used.  Thus, in this study, we set out to determine the effect of 
various doses of TCDD on intact adult mouse antral follicles on growth and steroid 
hormone production/secretion.  We specifically tested the hypothesis that TCDD 
exposure leads to decreased sex hormone production/secretion by antral follicles as 
well as decreased growth of antral follicles in vitro.  Since TCDD is known to act through 
binding to the transcription factor, the aryl hydrocarbon receptor (AHR), and the AHR 
has been identified as an important factor in ovarian function (Hernández-Ochoa et al., 
2009; Rowlands and Gustafsson, 1997), we also conducted experiments to confirm the 
presence and activation of the AHR in our tissue culture system.  Since our results 
indicate that TCDD inhibits steroidogenesis in antral follicles, we further investigated 
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whether we could restore steroid production/secretion in TCDD exposed follicles by co-
treating with pregnenolone, an early substrate in steroidogenesis.  
2.3 Materials and Methods 
Chemicals 
2,3,7,8-tetrachlorodibenzo-p-dioxin dissolved in dimethyl sulphoxide (DMSO) at 
50μg/mL (#ED-901-B) was purchased from Cambridge Isotope Laboratories, Inc., 
Andover, MA. Pregnenolone (P9129), DMSO (D2650), 100X insulin, transferrin, and 
selenium (ITS), penicillin and streptomycin were purchased from Sigma-Aldrich (St. 
Louis, MO).  Alpha minimal essential media (α-MEM) was purchased from Invitrogen 
(Carlsbad, CA).  Fetal bovine serum (FBS) was purchased from Atlanta Biologicals, 
Lawrenceville, GA.  Human recombinant follicle-stimulating hormone (hFSH) was 
obtained from Dr. A. F. Parlow, National Hormone and Peptide Program, Harbor-UCLA 
Medical Center, Torrance, CA.   
Animals 
CD-1 mice were purchased from Charles River and maintained in accordance 
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, 
and all protocols were approved by the University of Illinois Animal Care and Use 
Committee.  Upon arrival to the University of Illinois animal care facility, mice were 
allowed to acclimate for a minimum of 48 hours prior to tissue collection.  All mice were 
housed under strict 12L:12D lighting and temperature was maintained at 22±1ºC.  Food 
and water were provided ad libitum. 
In vitro mouse antral follicle culture 
Female mice were sacriﬁced by CO2 asphyxiation followed by cervical dislocation 
on postnatal day (PND) 33 and their ovaries removed.  Small antral follicles were 
isolated mechanically from the ovaries of 2-4 mice for each experiment based on 
relative size (200-350μm) and cleaned of interstitial tissue using ﬁne #5 watchmaker 
forceps in unsupplemented α-MEM.  Approximately 20–30 antral follicles were isolated 
from each mouse.  Follicles were then placed randomly one per individual well in a 96-
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well culture plate with α-MEM prior to treatment.  For each experiment, a minimum of 
eight follicles were plated per treatment group.  Supplemented α-MEM was prepared 
with 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 ng/ml selenium), 100 U/ml 
penicillin, 100 μg/ml streptomycin, 5 IU/ml hFSH, and 5% FBS.  To determine a dose 
response for TCDD in our culture system (0.1nM-100nM), 10 fold serial dilutions of 
TCDD were prepared from the original stock with vehicle DMSO (133μM, 13.3 μM, 
1.33μM, and 0.133μM).   The individual dilutions or vehicle alone were added to the 
supplemented α-MEM at an equal volume (0.75μL/mL media) to maintain the vehicle 
concentration at a constant of 0.075% for each treatment.  For treatment, 
unsupplemented α-MEM was removed from each well and replaced with 150μL of 
supplemented α-MEM containing vehicle or TCDD.  Follicles were then incubated for 96 
h at 37ºC in 95% air and 5% CO2. 
Similarly, for the cultures with TCDD and pregnenolone co-treatment, each 
chemical was added to the supplemented α-MEM such that each treatment contained 
the same volume of chemicals in combination or alone.  Specifically, pregnenolone was 
solubilized in DMSO at 26.7mM and some of this stock was diluted two fold to 13.3mM.  
Two stock solutions of TCDD were made: 2.66μM and 1.33μM.  Pregnenolone was 
added to the media for a final concentration of 10μM and TCDD was added to the 
media for a final concentration of 1nM.  Finally, follicles were incubated with vehicle, 
pregnenolone (10μM), TCDD (1nM), or pregnenolone (10 μM) and TCDD (1nM) for 96 h 
at 37ºC in 95% air and 5% CO2.  At least 3 individual experiments were performed for 
each treatment.        
Follicle growth analysis 
Antral follicles were cultured as described above for 96 h. Follicle growth was 
examined at 24 hour intervals by measuring follicle diameter on perpendicular axes with 
an inverted microscope equipped with a calibrated ocular micrometer. Small antral 
follicles were considered as those having diameters of 200-350μm (Smitz and 
Cortvrindt, 2002).  At least three separate culture experiments were performed for each 
chemical treatment. Follicle diameter measurements were averaged among treatment 
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groups and plotted as percent change in diameter from time zero to compare the effects 
of chemical treatments on growth over time. 
Measurement of sex steroid hormones by ELISA 
Media were collected after the 96 hours culture and frozen at -80ºC until they 
were subjected to enzyme-linked immunosorbent assays (ELISAs) for P4, A4, T, and 
E2 levels.  ELISA kits were purchased from DRG Diagnostics (USA) and procedures 
were followed using the manufacturer’s protocols.  The media were randomly selected 
from 8-23 wells and were assayed individually for each treatment group from 3-6 
experiments.  The intra-assay and inter-assay variabilities were less than 10%. 
Quantitative real time PCR analysis of Ahr and Cyp1b1 transcript levels 
At the end of each of the 96 hour cultures, 8-16 follicles from each treatment 
group were pooled and immediately snap frozen in liquid nitrogen and stored at -80ºC 
until RT-qPCR analysis.  Total RNA was extracted using the RNeasy Micro Kit with 
DNase treatment to eliminate potential genomic DNA contamination according to the 
manufacturer’s instructions (Qiagen, Valencia, CA).  Concentration, purity, and quality 
of the RNA were determined using the NanoDrop ND-1000 UV-Vis spectrophotometer 
at 260 nm and 280 nm (Nanodrop Technologies, Wilmington, DE).  Total RNA (250ng) 
was reverse transcribed using an iScript cDNA synthesis kit according to manufacturer’s 
instructions (Bio-Rad, Hercules, CA).  Negative controls included omission of reverse 
transcriptase and omission of template.  Each of the final cDNA samples were then 
diluted 1:4 for real time qPCR analysis. 
 All qPCR reactions were performed in triplicate using the CFX96 Real-time 
System C1000 Thermal Cycler (Bio-Rad).  Each qPCR reaction contained 5μL of 2X 
SsoFastTM Evagreen® supermix, 0.6μL of gene specific primers, 2.4μL of nuclease free 
water, and 2μL of diluted cDNA template.  The final concentration for each gene specific 
primer in the qPCR reactions was 0.3pmoles/ μL.  A BLASTN search was performed in 
GenBank to ensure that all primers were unique to the gene of interest. To avoid 
amplification from genomic DNA contamination, all primer sets spanned a large exon-
intron-exon junction.  Primer sequences were as follows: cytochrome P450, family 1, 
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subfamily b, polypeptide 1 (Cyp1b1) Forward 5’-GCG ACG ATT CCT CCG GGC TG- 3’, 
Cyp1b1 Reverse 5’ –TGC ACG CGG GCC TGA ACA TC- 3’, aryl hydrocarbon receptor 
(Ahr) Forward 5’-TTC TTA GGC TCA GCG TCA GCT A- 3’, Ahr Reverse 5’ -GCA AAT 
CCT GCC AGT CTC TGA T -3’, beta actin (Actb)  Forward 5’ –GGG CAC AGT GTG 
GGT GAC -3’, Actb Reverse 5’ –CTG GCA CCA CAC CTT CTA C -3’.  Initial 
denaturation of the cDNA and enzyme activation occurred at 95ºC for 1 min, followed by 
40 cycles of (10 seconds at 95ºC, 10 seconds at 60ºC, and a fluorescent absorbance 
reading), and one final annealing/elongation step for 5 minutes at 72ºC.  A heat 
dissociation curve (from 65ºC-95ºC with a fluorescent absorbance reading after each 
0.5ºC increment) was performed at the end of every run to assure specificity of each 
primer pair for the chosen transcript of interest.  
 For relative quantification of transcript levels, standard curves were generated 
using a six step serial dilution of cDNA generated from pooled RNA samples for each 
primer set being used (Actb, Ahr, and Cyp1b1).  These standard curves were used to 
calculate the amplification efficiencies for each primer pair.  Relative transcript amount 
was then calculated by a mathematical model developed by Pfaffl (Pfaffl, 2001).  Briefly, 
the method involves calculating the relative expression ratio of the target gene based on 
the amplification efficiency of each amplicon and the ΔCt of the treated samples versus 
the vehicle control.  These ratios were then compared to the expression of the reference 
gene Actb.  Actb was verified as a good internal control because its levels were 
unchanged with treatment (data not shown).  The data were reported as mean transcript 
expression ratios relative to Actb from 3-4 separate follicle culture experiments.         
 
Statistical Analysis 
Least squares one-way analysis of variance (ANOVA) was used to analyze the 
data followed by the Tukey’s post hoc test.  If the data did not pass the assumption of 
homogeneity of variance, the non-parametric Kruskal-Wallis ANOVA was performed 
followed by the Mann-Whitney test.  Statistical significance was assigned at p≤0.05 for 
all comparisons.  All data were analyzed using SPSS 11.0 statistical software (SPSS 
Inc., Chicago, IL). 
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2.4 Results 
Effect of TCDD exposure on antral follicle growth 
Antral follicle growth is mainly characterized by proliferation of granulosa cells 
and accumulation of follicular fluid in the antral space leading to an increase in follicle 
volume over time (Hirshfield, 1991).  To determine whether TCDD has an effect on 
follicle growth in vitro, follicle diameter was measured on a perpendicular axis every 24 
hours for a period of 96 hours.  TCDD had no effect on follicle growth at any of the four 
doses (0.1, 1, 10, and 100nM) when compared to vehicle alone (Fig 1).  Additionally, 
follicles exposed to TCDD or vehicle had a similar gross morphology at the beginning 
and at the end of the 96 hour cultures.  All follicles consisted of a single oocyte, an 
antrum, multiple layers of healthy granulosa cells, and a thecal layer surrounding the 
oocyte (Fig 2).    
Effect of TCDD exposure on antral follicle steroid secretion 
Antral follicles are the primary source of female sex steroid hormone production 
(Edson et al., 2009).  To determine whether TCDD has an effect on antral follicle steroid 
hormone production, follicles were treated with TCDD and the media were collected at 
the end of the 96 hour culture and assayed for levels of P4, A4, T, and E2.  TCDD 
exposure for 96 hours resulted in U-shaped dose response curves for the amount of P4, 
A4, T, and E2 secreted into the media by the antral follicles in vitro when compared to 
vehicle alone (Fig 3).  Specifically, the level of P4 was significantly decreased only at 
the 1nM dose of TCDD and not at the lowest (0.1nM) and two highest (10 and 100nM) 
doses of TCDD (Fig 3 a).  The levels of androgens (A4 and T) were significantly 
decreased at the two lowest doses of TCDD (0.1 and 1nM), but not at the two highest 
doses (10 and 100nM) of TCDD (Fig 3 b and c).  E2 levels were decreased after 
exposure to 0.1, 1, and 10nM, but not after exposure to the highest dose of TCDD 
(100nM) (Fig 3 d).  Interestingly, only the 1nM dose of TCDD significantly decreased the 
level of all four hormones simultaneously.      
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Effect of co-treatment of TCDD and pregnenolone on antral follicle growth and steroid 
secretion 
  To determine whether the decrease in hormone levels observed in the follicle 
culture media after 96 hours TCDD exposure was due to impaired StAR or P450scc 
function, pregnenolone was supplemented in the media with or without 1nM TCDD.  
The 1nM dose was chosen because this dose impairs the production or secretion of all 
four of the steroid hormones of interest (Fig 3).  Antral follicle growth was monitored 
every 24 hours and the media were collected at the end of the 96 hour period for 
hormone assays.  As demonstrated in the dose response experiments (Fig 3), exposure 
to 1nM TCDD for 96 hours again resulted in decreased production/ secretion of P4, A4, 
T, and E2 by the antral follicles in culture when compared to vehicle alone (Fig 4 a-d).  
Pregnenolone co-treatment restored hormone levels to control levels, suggesting a 
block in the steroidogenic pathway prior to pregnenolone formation, possibly via a StAR 
or P450scc impairment (Fig 4 a-d).  Although pregnenolone co-treatment restored sex 
steroid hormone levels in the media, it did not alter antral follicle growth (Fig 5).   
Effect of TCDD exposure on the expression of Ahr and Cyp1b1 in antral follicles  
AHR activation by TCDD has been shown to increase metabolism of E2 by 
inducing the cytochrome P450 monooxygenases, such as CYP1B1 (Hayes et al., 1996; 
Spink et al., 2003).  Thus, follicles were subjected to real time qPCR for levels of Ahr 
and Cyp1b1 mRNA.  TCDD exposure resulted in a three to four-fold induction of 
Cyp1b1 expression in antral follicles regardless of the dose after 96 hours of culture, 
evidence of AHR pathway activation (Fig 6 a).  Additionally, TCDD did not affect the 
expression level of Ahr mRNA in cultured antral follicles regardless of the dose (Fig 6 
b).   
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2.5 Discussion 
To our knowledge, studies have not reported the direct effects of TCDD on 
mouse antral follicles in vitro.  In fact, only one published study has reported on direct 
effects of TCDD on steroidogenesis and growth in follicles isolated from cycling animals 
in vitro and this study was conducted using pig follicles (Grochowalski et al., 2000).  The 
follicle culture system we used in this study has been well characterized and has been 
proven to be an excellent model for in vitro testing of ovarian function in reproductive 
toxicology studies (Cortvrindt and Smitz, 2002; Gupta et al., 2006).  The cultured 
follicles maintain much of their steroidogenic and proliferative capacity throughout the 
96 hour culture period; maintaining the presence of granulosa cells, theca cells, a 
basement membrane and oocytes in meiotic arrest (Cortvrindt et al., 1997). Thus, unlike 
studies utilizing primary granulosa cells or human luteinized granulosa cells in culture, 
all the functional compartments of the follicle are present in our system.  In addition, we 
also chose a series of TCDD doses previously shown to have effects on ovarian tissues 
and cells in culture, which also encompass environmentally relevant (0.1 and 1nM) as 
well as pharmacological exposures (10nM and 100nM),  so that we could determine a 
dose response for TCDD in our culture system (Birnbaum and DeVito, 1995; 
Gregoraszczuk, 2002).        
Proliferation of follicular cells contributes to the overall growth of follicles 
(Hirshfield, 1991).  Our data indicate that TCDD does not affect growth of follicles, 
suggesting that it does not affect proliferation of granulosa cells in mice.  These data 
differ from those obtained using pig follicles and from in vivo dosing experiments in rats.  
Specifically, Grochowalski et al. found that TCDD reduced the percentage of 
proliferating cells in porcine follicles over time and that this was attributed to increasing 
accumulation of TCDD in the tissue over time (Grochowalski et al., 2000).  Heimler et al. 
found a decrease in the number of antral follicles without an increase in atresia in the 
ovaries of TCDD exposed rats suggesting an anti-proliferative effect (Heimler et al., 
1998b).  While it is unclear why our results differ from others, it is likely due to species 
differences or differing experimental conditions.    
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We also found that TCDD alters steroidogenesis in mouse follicles in a non-
monotonic/ U-shaped dose response manner.  These data are consistent with studies in 
other species and culture systems (Dasmahapatra et al., 2000; Gregoraszczuk, 2002; 
Grochowalski et al., 2000; Heimler et al., 1998a).  Specifically, in studies utilizing 
isolated porcine thecal and granulosa cell co-cultures, TCDD exposures of 0.1nM or 
10nM resulted in reduced E2 accumulated in the media, while only the 10nM exposure 
resulted in a significant reduction in progesterone in the media after 96 hour cultures 
(Grochowalski et al., 2001).  Further, unlike our results for E2 levels in the media after 
TCDD exposure, Gregoraszczuk et al. observed a dose response decrease in E2 levels 
with increasing TCDD concentration up to 100nM in the media after only 48 hours of 
culture (Gregoraszczuk, 2002).  We did not observe a significant decrease after 
exposure to the highest dose of TCDD (100nM) after 96 hours.  This difference could be 
due to time dependent effects of TCDD on steroidogenesis in follicles.  Studies 
comparing single versus prolonged exposures to TCDD on steroidogenesis in pig 
follicles have revealed a varying response with a decrease and an increase in 
testosterone levels, respectively (Grochowalski et al., 2000).  It is also possible that at 
pharmacological doses of TCDD, steroidogenesis is able to recover after prolonged 
TCDD exposure such as was demonstrated in porcine luteal cells and in human 
luteinized granulosa cells in culture (Gregoraszczuk et al., 2000; Heimler et al., 1998a).  
This could be an explanation for the lack of effect we observed on the levels of P4, A4, 
T and E2 assayed from the mouse follicles exposed to the highest pharmacological 
dose of TCDD (100nM) in the media after 96 hours in culture.  Interestingly, only the 
1nM dose of TCDD significantly inhibited the accumulation of P4 in the media after 96 
hours culture.  These results suggest that like hormones and other environmental 
contaminants that act as endocrine disruptors, TCDD may have multiple modes of 
action in mouse antral follicles depending on the dose (Gierthy, 2002; Gore et al., 
2006). 
Since P4 accumulation in the media was decreased after TCDD exposure and 
P4 synthesis is early in the steroidogenic pathway, we investigated whether we could 
by-pass this effect with pregnenolone substrate co-treatment with the 1nM dose of 
TCDD.  Addition of pregnenolone substrate restored P4 in the media to control levels, 
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suggesting that TCDD could be acting on StAR or P450scc function in mouse antral 
follicles.  Similar to our findings, Gregoraszczuk et al. were able to restore P4 levels 
after co-treatment with pregnenolone and TCDD in porcine granulosa thecal cell co-
cultures (Gregoraszczuk, 2002).  Supportive of this observation, TCDD has been shown 
to activate the AHR, leading to transcriptional regulation of the promoter activities of 
P450scc, the mitochondrial enzyme responsible for cleaving cholesterol to 
pregnenolone in the steroidogenenic pathway (Dasmahapatra et al., 2000).  
Specifically, Dasmahapatra et al. found a reduction in the level of P450scc mRNAs in 
isolated rat granulosa cells exposed to TCDD (Dasmahapatra et al., 2000).  Contrary to 
this finding, studies investigating the effects of TCDD on steroidogenesis in rat testes 
and adrenal glands in vivo suggest that TCDD may not directly act on inhibiting 
P450scc activity or levels, but may inhibit the mobilization of cholesterol to P450scc;  
ultimately leading to a decrease in hormone levels (DiBartolomeis et al., 1987; Kleeman 
et al., 1990; Moore et al., 1991).    Though it was not directly tested in this study, it is 
likely that at the 1nM dose, TCDD does not affect downstream enzymes in the 
steroidogenic pathway since pregnenolone co-treatment also restored A4, T, and E2 
accumulation in the media.     
Since androgen and E2 levels were also decreased at doses of TCDD when P4 
levels were not affected, it is likely that TCDD acts downstream of pregnenolone 
formation in the steroidogenic pathway in the follicle as well.  This is supported by 
several studies utilizing porcine granulosa thecal cell co-cultures, rat granulosa cell 
cultures and human luteinized granulosa cell cultures.  Gregoraszczuk found evidence 
of reduced aromatase activity in porcine granulosa and thecal cell co-cultures after 
TCDD exposure (Gregoraszczuk, 2002).  Similarly, studies conducted using FSH-
stimulated rat granulosa cells found that the addition of A4 partially restored E2 levels.  
Upon further investigation, they found that TCDD inhibited the FSH-stimulated increase 
in aromatase activity usually exhibited by these cells, indicating possible actions on this 
enzyme as well as the follicle stimulating hormone receptor (Dasmahapatra et al., 
2000).  Studies exposing human luteinized granulosa cells (hLGCs) to TCDD in culture 
also found a decrease in E2 accumulation in the media after TCDD exposure, but 
contrary to the studies using rat granulosa cells, Morán et al. did not find a decrease in 
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aromatase levels or activity (Morán et al., 2000).  Instead, they demonstrated that the 
reduced E2 was the result of an impairment in the supply of aromatizable androgens 
due to a decrease in the lyase activity of 17α hydroxylase/ 17,20 lyase cytochrome 
P450 (CYP17A1) enzyme as well as decreased levels of CYP17A1 protein levels in 
hLGCs (Morán et al., 2003a; Morán et al., 2003b).  
Other mechanisms by which TCDD could be affecting hormone levels in the 
follicle are through an AHR pathway that drives transcriptional activation of genes 
responsible for E2 catabolism.  AHR transcriptional activation via TCDD ligand binding 
has been shown to increase catabolism of E2 by inducing the cytochrome P450 
monooxygenases such as CYP1B1 (Badawi et al., 2001; Hayes et al., 1996).  CYP1B1 
is responsible for converting E2 to the catecholestrogen 4-hydroxyestradiol (Badawi et 
al., 2001).  CYP1B1 is expressed in the ovary in the absence of exogenous ligands and 
it is hormonally regulated and inducible by TCDD (Bhattacharyya et al., 1995; Brake 
and Jefcoate, 1995; Dasmahapatra et al., 2002; Otto et al., 1992; Savas et al., 1994; 
Shen et al., 1993; Shen et al., 1994; Sutter et al., 1994). Additionally, it has been shown 
in porcine granulosa cells that the AHR shuttles from the cytoplasm into the nucleus in 
the presence of TCDD, evidence of transcriptional activity in the ovary (Wojtowicz et al., 
2005).  Thus, we tested the hypothesis that TCDD exposure transcriptionally activates 
the AHR and induces Cyp1b1 leading to increased levels of Ahr and Cyp1b1 mRNA in 
our cultured antral follicles.  Interestingly, we did not observe an increase in Ahr 
transcript levels after TCDD exposure similar to what was observed in rat and porcine 
granulosa cells in culture (Dasmahapatra et al., 2001; Wojtowicz et al., 2005).  This 
could be due to the longer exposure we employed, or because the presence of thecal 
cells may conceal the effects on granulosa cells in antral follicle cultures.  Currently, 
very little is known about  how TCDD regulates AHR levels in the ovary, though it has 
been suggested that the aryl hydrocarbon receptor repressor (AHRR) plays a role in the 
absence of exogenous ligands, and this regulation might be at the protein level since 
Ahr mRNA levels remain unchanged in ovaries from gonadotropin primed mice (Baba et 
al., 2005).   
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Although we did not find any significant changes in Ahr transcript levels, we did 
observe a 3-4 fold increase in Cyp1b1 levels following 96 hours of TCDD exposure (0.1-
100nM), which is slightly higher than was observed in isolated rat granulosa cells 
exposed to TCDD for only 6 hours (3.1nM) (Dasmahapatra et al., 2002).  These findings 
strongly suggest and agree with the majority of published data that in addition to the 
effects of TCDD on the steroidogenic pathway, TCDD exposure may also lead to 
increased catabolism of E2 to catecholestrogens in the ovary.  
This idea is further supported by studies that found that acute exposure to TCDD 
in the ovariectomized rat decreases the elimination constant and clearance of E2 
(Petroff and Mizinga, 2003).  This could be one explanation for why contrary to our 
findings in vitro, circulating E2 levels were unaltered following in vivo TCDD exposure in 
CD-1 mice (DeVito et al., 1992).  It could be that TCDD exposure decreases E2 
synthesis and increases E2 catabolism in the mouse ovary, while it does not change 
circulating levels due to a slower clearance rate.  The lack of effect on E2 levels after 
the in vivo TCDD exposure in CD-1 mice could also be related to the route of 
administration, the age of the animals and the stage of the reproductive cycle.  Studies 
conducted using rats show that circulating E2 levels do not change in a gonadotropin 
primed immature hypophysectomized model with a very high single exposure to TCDD, 
while chronic exposure to low doses in utero lead to lower  levels of circulating E2 in 
pubertal life (Son et al., 1999; Franczak et al., 2006). Though TCDD metabolites have 
not been measured from follicles exposed to TCDD in vitro, ovaries express a battery of 
enzymes known to metabolize TCDD such as CYP1B1 (Bengtsson AND Rydstrom; 
1983; Dasmahapatra et al. 2002).  Thus, it is likely that some of the local effects of 
TCDD on the ovary could be due to actions of its metabolites on steroidogenesis as 
well.        
In conclusion, we have demonstrated that TCDD disrupts sex steroid hormone 
production in a non-monotonic dose response manner without altering growth of mouse 
antral follicles.  We were able to by-pass the disrupted steroid hormone production with 
pregnenolone co-treatment, suggesting that TCDD may be involved in inhibiting the 
mobilization of cholesterol to the inner mitochondrial membrane and/or in the 
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conversion of cholesterol to pregnenolone in antral follicles.  These actions of TCDD on 
steroid hormone metabolism are likely through an AHR pathway, as demonstrated by 
induction of the Cyp1b1 transcript and constitutive expression of the Ahr in our culture 
system.  Overall, the experimental results reported here and by others demonstrate 
complex actions of TCDD toxicity in the ovary.  Since humans and animals are exposed 
to a mixture of dioxins and other environmental toxicants, it will be important in the 
future to study the toxicity of these environmentally relevant mixtures. 
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2.6 Figures 
 
Fig 1 
Effect of TCDD on mouse antral follicle growth in vitro.  Antral follicles were 
mechanically isolated from young cycling CD1 mice and exposed for 96 hours in culture 
to TCDD (0.1nM-100nM) or vehicle alone.  The follicle diameters were measured every 
24 hours for a period of 96 hours.  Follicle growth was plotted as percent change in 
diameter over time from the beginning of the culture.  The graph represents the means 
±SEM from at least three individual experiments (n=8-16 follicles per treatment group 
per individual experiment).   
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Fig 3 
Effect of TCDD on mouse antral follicle sex steroid hormone secretion in vitro.  
Antral follicles were mechanically isolated from young cycling CD1 mice and exposed 
for 96 hours in culture to TCDD (0.1nM-100nM) or vehicle alone.  After the 96 hour 
culture period, media were collected and subjected to hormone assays for (A) 
progesterone, (B) androstenedione, (C) testosterone, and (D) estradiol levels.  The 
graphs represent the mean hormone levels ±SEM from 8-23 culture wells from a 
minimum of three separate follicle culture experiments.   Bars with different letters are 
significantly different from each other (p≤0.05). 
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Fig 4  
Effect of pregnenolone substrate co-treatment with TCDD on mouse antral follicle 
steroid hormone secretion in vitro.  Mouse antral follicles were treated with vehicle 
(DMSO), pregnenolone (10μM), TCDD (1nM), or TCDD (1nM) and pregnenolone (10 
μM) for 96 hours in culture.  After the 96 hour culture, media were collected and 
subjected to hormone assays for (A) progesterone, (B) androstenedione, (C) 
testosterone, and (D) estradiol levels.  The graphs represent the mean hormone levels 
±SEM from 8-23 culture wells from a minimum of three separate follicle culture 
experiments.  Bars with different letters are significantly different from each other 
(p≤0.05).  Preg = pregnenolone.   
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Fig 5 
Effect of pregnenolone substrate co-treatment with TCDD on mouse antral follicle 
growth in vitro.  Mouse antral follicles were treated with vehicle (DMSO), 
pregnenolone (10μM), TCDD (1nM), or TCDD (1nM) and pregnenolone (10 μM) for 96 
hours in culture.  The follicle diameters were measured every 24 hours for a period of 
96 hours.  Follicle growth was plotted as percent change in diameter over time from the 
beginning of the culture.  The graph represents the means ±SEM from at least three 
individual experiments (n=8-16 follicles per treatment group per individual experiment).   
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Fig 6 
Effect of TCDD exposure on the expression of Cyp1b1 and Ahr transcripts in 
antral follicles in vitro.  At the end of each of the 96 hour cultures, 8-16 follicles from 
each treatment group were pooled and immediately snap frozen in liquid nitrogen and 
assayed by real time qPCR for levels of (A) Cyp1b1 and (B) Ahr.  Levels of Cyp1b1 and 
Ahr were normalized to beta actin (Actb). Data are expressed as mean relative 
expression ratios ± SEM calculated from 3 - 4 separate culture experiments.  Bars with 
different letters are significantly different from each other (p≤0.05).   
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Chapter III: Dioxin exposure reduces the steroidogenic capacity of mouse antral follicles 
mainly at the level of HSD17B1 without altering atresia  
 
3.1 Abstract 
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent ovarian toxicant.  Previously, we 
demonstrated that in vitro TCDD (1nM) exposure decreases production/secretion of the 
sex steroid hormones progesterone (P4), androstenedione (A4), testosterone (T), and 
17β-estradiol (E2) in antral follicles.  The purpose of this study was to determine the 
mechanism by which TCDD inhibits steroidogenesis.  Specifically, we examined the 
effects of TCDD on the steroidogenic enzymes, atresia, and the aryl hydrocarbon 
receptor (AHR) protein.  TCDD exposure for 48 hours increased levels of A4, without 
changing hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 
(HSD3B1) protein, hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1) protein, 
estrone (E1), T or E2 levels.  Further, TCDD did not alter atresia rating compared to 
vehicle at 48 hours.  TCDD, however, did down regulate the AHR protein at 48 hours.  
TCDD exposure for 96 hours decreased transcript levels for cytochrome P450, family 
11, subfamily a, polypeptide 1 (Cyp11a1), cytochrome P450, family 17, subfamily a, 
polypeptide 1 (Cyp17a1), Hsd17b1, and cytochrome P450, family 19, subfamily a, 
polypeptide 1 (Cyp19a1), but increased Hsd3b1 transcript.  TCDD exposure particularly 
lowered both Hsd17b1 transcript and HSD17B1 protein.  However, TCDD exposure did 
not affect levels of E1 in the media nor atresia ratings after 96 hours.  Collectively, these 
data suggest that TCDD causes a major block in the steroidogeneic enzyme conversion 
of A4 to T and E1 to E2 and that this block is not due to TCDD induced cell death.   
Finally, the down regulation of the AHR protein in TCDD exposed follicles persisted at 
96 hours, indicating that the activation and proteasomal degradation of this receptor 
likely plays a central role in the impaired steroidogenic capacity of exposed antral 
follicles.  Overall, these data support the hypothesis that TCDD toxicity in the ovary is in 
part due to its effects on the steroidogenic enzymes, particularly on HSD17B1, and its 
ability to chronically down regulate the AHR protein without affecting atresia in antral 
follicles.    
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3.2 Introduction 
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic member of a class 
of chemicals called dioxins and is a persistent contaminant found in the human food 
chain, in the waterways, and in the air due to industrial waste (Birnbaum and DeVito 
1995; Frakes et al., 1993; Hites 2011; Tuppurainen et al., 2003).  TCDD has a long half-
life in the body and can remain for more than 10 years in humans after a single 
exposure due to its highly lipophilic nature, slow metabolism, and slow excretion 
(Miniero et al., 2001; Sorg et al., 2009).  Dioxins, like TCDD, have been detected in 
human fat tissue, blood serum, breast milk, and ovarian follicular fluid (Birnbaum and 
DeVito 1995; Humblet et al., 2011; Schecter et al., 2006; Tsutsumi et al., 2011; 
Ulaszewska et al., 2011).  TCDD is an endocrine disruptor and potent ovarian toxicant.  
Numerous studies show that besides its actions on the hypothalamus-pituitary axis to 
disrupt reproductive processes such as ovulation in rats, TCDD acts directly on ovarian 
follicles (Cao et al., 2011; Gao et al., 2001; Mizuyachi et al., 2002; Petroff et al., 2000; 
Petroff et al., 2001; Petroff et al., 2003).   
Studies also indicate that TCDD acts directly on antral follicles and inhibits 
steroidogenesis.  The antral follicle is the main functional unit of the ovary, and is the 
primary source of sex steroid hormones in females.  The process of sex steroid 
hormone synthesis in the rodent antral follicle (see diagram 1) begins in the thecal cells 
and involves mobilization of cholesterol into the inner mitochondrial membrane via 
steroidogenic acute regulatory protein (STAR) where it is cleaved by the enzyme 
CYP11A1 to pregnenolone (P5).  The thecal smooth endoplasmic reticulum is the site 
for hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 
(HSD3B1) isozyme conversion of P5 to progesterone (P4) and dehydroepiandrosterone 
(DHEA) to androstenedione (A4); and for the conversion of P5 to DHEA under 
cytochrome P450, family 17, subfamily a, polypeptide 1 (CYP17A1).  A4 then diffuses 
across the basement membrane to the granulosa cells where it is either aromatized by 
cytochrome P450, family 19, subfamily a, polypeptide 1 (CYP19A1) to estrone (E1) and 
converted via hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1) to estradiol-17β 
(E2), or metabolized to testosterone (T) via HSD17B1.  T is then aromatized to E2 by 
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CYP19A1 (for a more detailed review of ovarian steroidogenesis, see (Edson et al., 
2009). 
 Previously, we demonstrated that an environmentally relevant exposure to 
TCDD (1nM) leads to reduced sex steroid hormone production/secretion by intact 
mouse antral follicles, without affecting their growth in vitro (Karman et al., 2012).  
Further, we were able to bypass the reduced hormone production/secretion by co-
treatment with pregnenolone, an early substrate in the sex steroid hormone synthesis 
pathway, suggesting that TCDD may inhibit cholesterol mobilization or its metabolism to 
P5 by CYP11A1 in the mouse ovary.  Thus, one goal of the current studies was to 
determine which enzymes in the steroidogenic pathway are affected by TCDD exposure 
in antral follicles.  We focused on the effects of TCDD on CYP11A1 and HSD3B1 
because they are critical enzymes present in the thecal cells necessary for the reduction 
of cholesterol to P5 and P5 to A4.  We also focused on HSD17B1 and CYP19A1 
because these enzymes are critical for interconverting A4 to T, E1, and E2 in the 
granulosa cell compartment of the follicle.    
Another process in the ovary that can affect steroidogenesis is cell death.  During 
the process of folliculogenesis in the ovary, most of the follicles (>95%) undergo a 
process of programmed cell death called atresia and are eventually eliminated from the 
ovary (Kaipia and Hsueh 1997).  Any alteration in the tight balance between follicle 
atresia and survival can lead to decreased sex steroid hormone levels and/or infertility.  
Currently, it is unclear whether TCDD increases programmed cell death in the ovary.  
Some studies indicate that rats exposed to TCDD do not have an increase in the 
number of atretic pre-antral and antral follicles in their ovaries, while other studies 
indicate that TCDD exposure increases apoptosis in human luteinized granulosa cells 
(Heimler et al., 1998a; Heimler et al., 1998b).  Thus, a second goal of the proposed 
studies was to determine if TCDD induces atresia in isolated antral follicles.    
  Finally, TCDD is a known ligand of the protein transcription factor, the AHR.   
The AHR has been identified as an important player in ovarian function, including 
steroidogenesis (Hernández-Ochoa et al., 2009).   When the AHR is not bound to ligand 
such as TCDD, it is primarily located in the cytoplasm of the cell where it associates 
with various heat shock proteins (Gu et al., 2000; Pocar et al., 2005; Whitlock 1999).  
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When it is bound to TCDD, it goes through a conformational change which allows it to 
enter the nucleus.  Once in the nucleus, it can bind to proteins such as the aryl 
hydrocarbon receptor nuclear tanslocator (ARNT) and act as a transcription factor by 
binding to various regulatory elements within the promoters of responsive genes such 
as cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1), which is 
responsible for biotransformation of TCDD and E2 catabolism (Badawi et al., 2001; 
Bhattacharyya et al., 1995; Otto et al., 1992).  Further, it has been demonstrated in 
numerous cell and tissue types that TCDD can provoke AHR protein degradation via a 
ubiquitin-proteasome pathway without altering levels of AHR mRNA (Giannone et al., 
1998; Pollenz 2002; Prokipcak and Okey 1991; Roberts and Whitelaw 1999).  Thus, the 
final goal of these studies was to determine the effects of TCDD on AHR protein levels 
in antral follicles.   
 
 
3.3 Materials and methods 
 
 
Chemicals 
TCDD dissolved in dimethyl sulphoxide (DMSO) at 50μg/mL (#ED-901-B) was 
purchased from Cambridge Isotope Laboratories, Inc., Andover, MA. DMSO (D2650), 
100X insulin, transferrin, and selenium (ITS), penicillin and streptomycin were 
purchased from Sigma-Aldrich (St. Louis, MO).  Alpha minimal essential media (α-MEM) 
was purchased from Invitrogen (Carlsbad, CA).  Fetal bovine serum (FBS) was 
purchased from Atlanta Biologicals, Lawrenceville, GA.  Human recombinant follicle-
stimulating hormone (hFSH) was obtained from Dr. A. F. Parlow, National Hormone and 
Peptide Program, Harbor-UCLA Medical Center, Torrance, CA.   
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Animals 
CD-1 mice were purchased from Charles River and maintained in accordance 
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, 
and all protocols were approved by the University of Illinois Animal Care and Use 
Committee.  Upon arrival to the University of Illinois animal care facility, mice were 
allowed to acclimate for a minimum of 48 hours prior to tissue collection.  All mice were 
housed under strict 12L:12D lighting and temperature was maintained at 22±1ºC.  Food 
and water were provided ad libitum. 
 
In vitro mouse antral follicle culture 
Female mice were euthanized by CO2 asphyxiation followed by cervical 
dislocation on postnatal day (PND) 33 and their ovaries were removed.  Small antral 
follicles were isolated mechanically from the ovaries of 2-4 mice for each experiment 
based on relative size (250-350μm) and cleaned of interstitial tissue using ﬁne #5 
watchmaker forceps in unsupplemented α-MEM.  Approximately 20–30 antral follicles 
were isolated from each mouse.  Follicles were then placed randomly one per individual 
well in a 96-well culture plate with α-MEM prior to treatment.  For each experiment, a 
minimum of eight follicles were plated per treatment group.  Supplemented α-MEM was 
prepared with 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 ng/ml selenium), 100 
U/ml penicillin, 100 μg/ml streptomycin, 5 IU/ml hFSH, and 5% FBS.  TCDD or vehicle 
alone was added to the supplemented α-MEM at an equal volume (0.75μL/mL media) to 
maintain the vehicle concentration at a constant of 0.075% for each treatment.  For 
treatment, unsupplemented α-MEM was removed from each well and replaced with 
150μL of supplemented α-MEM containing vehicle or 1nM TCDD.  We elected to use 
1nM TCDD because this environmentally relevant dose significantly affected sex steroid 
hormone production/secretion in antral follicles in a previous study (Karman BN et al., 
2012).  Follicles were then incubated for either 48 or 96 h at 37ºC in 95% air and 5% 
CO2. 
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Measurement of sex steroid hormones 
Media were collected after the 48 or 96 hours culture and frozen at -80ºC until 
they were subjected to enzyme-linked immunosorbent assays (ELISAs) for A4, T, E1 
and E2 levels.  ELISA kits were purchased from DRG Diagnostics (USA) and 
procedures were followed using the manufacturer’s protocols.  The media were 
randomly selected from 8-23 wells and were assayed individually for each treatment 
group from 3-6 experiments.  The intra-assay and inter-assay variabilities were less 
than 10%. 
 
Analysis of transcript levels 
At the end of the cultures, 8-16 follicles from each treatment group were pooled 
and immediately snap frozen in liquid nitrogen and stored at -80ºC until quantitative real 
time PCR (qPCR) analysis.  Total RNA was extracted using the RNeasy Micro Kit with 
DNase treatment to eliminate potential genomic DNA contamination according to the 
manufacturer’s instructions (Qiagen, Valencia, CA).  Concentration, purity, and quality 
of the RNA were determined using the NanoDrop ND-1000 UV-Vis spectrophotometer 
at 260 nm and 280 nm (Nanodrop Technologies, Wilmington, DE).  Total RNA (250ng) 
was reverse transcribed using an iScript cDNA synthesis kit according to manufacturer’s 
instructions (Bio-Rad, Hercules, CA).  Negative controls included omission of reverse 
transcriptase and omission of template.  Each of the final cDNA samples were then 
diluted 1:4 for real time qPCR analysis. 
 All qPCR reactions were performed in triplicate using the CFX96 Real-time 
System C1000 Thermal Cycler (Bio-Rad).  Each qPCR reaction contained 5μL of 2X 
SsoFastTM Evagreen® supermix, 0.6μL of gene specific primers, 2.4μL of nuclease free 
water, and 2μL of diluted cDNA template.  The final concentration for each gene specific 
primer in the qPCR reactions was 0.3pmoles/ μL.  A BLASTN search was performed in 
GenBank to ensure that all primers were unique to the gene of interest. To avoid 
amplification from genomic DNA contamination, all primer sets spanned a large exon-
intron-exon junction.  Primer sequences are shown in table 1.  Initial denaturation of the 
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cDNA and enzyme activation occurred at 95ºC for 1 min, followed by 40 cycles of (10 
seconds at 95ºC, 10 seconds at 60ºC, and a fluorescent absorbance reading), and one 
final annealing/elongation step for 5 minutes at 72ºC.  A heat dissociation curve (from 
65ºC-95ºC with a fluorescent absorbance reading after each 0.5ºC increment) was 
performed at the end of every run to assure specificity of each primer pair for the 
chosen transcript of interest.  
 For relative quantification of transcript levels, standard curves were generated 
using a six step serial dilution of cDNA generated from pooled RNA samples for each 
primer set being used.  These standard curves were used to calculate the amplification 
efficiencies for each primer pair.  Relative transcript amount was then calculated by a 
mathematical model developed by Pfaffl (Pfaffl MW 2001).  Briefly, the method involves 
calculating the relative expression ratio of the target gene based on the amplification 
efficiency of each amplicon and the ΔCt of the treated samples versus the vehicle 
control.  These ratios were then compared to the expression of the reference gene Actb.  
Actb was verified as a good internal control because its levels were unchanged with 
treatment (data not shown).  The data were reported as mean transcript expression 
ratios relative to Actb from 3-4 separate follicle culture experiments.   
 
 
Analysis of protein levels 
At the end of each of the cultures, 12-16 follicles from each treatment group were 
pooled and immediately snap frozen in liquid nitrogen and stored at -80ºC until analysis 
by western blot.  The pooled follicles were then lysed and homogenized in 20 μl T-Per 
(Thermo Fisher Scientific, Rockford, IL) containing protease inhibitors (Roche 
Diagnostics, Mannheim, Germany).  For positive and negative controls, a PND 33 
female mouse was euthanized as previously described and the ovaries, heart, lung, and 
a biopsy of skeletal muscle was removed and immediately snap frozen and stored at -
80ºC until analysis by western blot.  Tissues were lysed and homogenized in T-Per 
containing protease inhibitors according to manufacturer’s instructions. After tissue 
lysis, homogenization, and centrifugation, the protein concentration in the supernatant 
59 
 
was determined by using a bicinchoninic acid (BCA) assay kit (Thermo Fisher Scientific, 
Rockford, IL). Electrophoresis and immunoblotting were performed using XCell 
SureLock Mini-Cell Blot Module Kit and recommended reagents as per manufacturer's 
protocol (Invitrogen, Carlsbad, CA). The protein lysate (2 μg) was loaded on precast 4–
12% bis-tris sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE; Invitrogen, 
Carlsbad, CA), followed by transfer of the proteins to 0.45μm InvitralonTM polyvinylidene 
difluoride membranes (Invitrogen, Carlsbad, CA) at 4 °C. The blots were blocked with 
5% non-fat milk for one hour at room temperature and then incubated overnight at 4 °C 
with primary antibodies.  The primary antibodies and concentrations used were as 
follows: CYP11A1 (C-16) sc-18043, 1:100 (Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA), 3β-HSD (P-18) sc-30820, 1:200 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 
HSD17B1 NBP1-56295, 0.5 μg/mL (Novus Biologicals, Littleton, CO), CYP19 (C-16) sc-
14245, 1:200 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and AHR BML-SA210, 
1:5000 (Enzo Life Sciences, Plymoth Meeting, PA).  After three washes, the 
membranes were then incubated for one hour at room temperature with the appropriate 
horseradish peroxidase (HRP) conjugated secondary antibody.  The secondary 
antibodies and concentrations used were as follows goat anti-Rabbit HRP ab6721, 
1:5000 (Abcam Inc., Cambridge, MA) or donkey anti-Goat HRP sc-2020, 1:5000 (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA).  To ensure uniform loading of the proteins, 
the blots were then incubated with the anti-beta actin antibody (ACTB) ab8227, 1:5000 
(Abcam Inc., Cambridge, MA).  The immune complexes on the blots were visualized 
using an enhanced chemiluminescence detection kit (Cell Signaling Technologies, 
Danvers, MA) and captured on X-ray film. Scanning densitometry using the Image J 
software downloaded from the NIH website (http://rsb.info.nih.gov/ij/) was used to 
compare the protein levels. Specifically, densitometric units of the CYP11A1, HSD3B1, 
HSD17B1, CYP19A1, and AHR protein bands were normalized to the densitometric 
units of the corresponding ACTB protein bands on each blot for quantification. 
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Analysis of atresia 
At the end of each follicle culture experiment, supplemented α-MEM was 
removed from each well and Dietrich’s solution was immediately added to fix the 
follicles.  The tissues were dehydrated, embedded in cold-curing Technovit 7100 plastic 
resin (EB Sciences, Germany), serially sectioned (2μm), mounted on charged glass 
slides, and stained with Lee’s methylene blue-basic fuchsin. Each follicle section 
containing the oocyte was examined for the level of atresia as evidenced by the 
presence of pyknotic bodies.  Data are reported as the average percentage of pyknotic 
bodies to total cell number for each follicle section examined from 8-10 follicles per 
treatment group from 4 separate follicle culture experiments.  Follicles were rated on a 
scale of 1–4 for the percentage of pyknotic bodies present as previously described 
(Miller et al., 2006; Paulose et al., 2012): a rating of 1 is a healthy follicle, a rating of 2 is 
an early atretic follicle with <10% pyknotic bodies, a rating of 3 is a mid atretic follicle 
with 10–30% pyknotic bodies, and a rating of 4 is a late atretic follicle with >30% 
pyknotic bodies.  All analyses were conducted without knowledge of treatment group. 
Ratings were averaged and plotted to compare the effect of TCDD on atresia levels.  
 
Statistical Analysis 
Independent samples t-tests were used to analyze the data.  If the data did not 
pass the assumption of homogeneity of variance, the non-parametric Mann-Whitney U 
test was employed.  Statistical significance was assigned at p≤0.05 for all comparisons.  
All data were analyzed using SPSS 11.0 statistical software (SPSS Inc., Chicago, IL). 
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3.4 Results 
 
 
Effect of TCDD exposure on antral follicle steroid secretion 
Previously, we determined that in vitro TCDD (1nM) exposure in antral follicles 
decreases levels of P, A4, T and E2 in the media at 96 hours (Karman et al., 2012).  To 
determine when TCDD has an effect on antral follicle steroid hormone 
production/secretion, antral follicles were cultured for 48 hours with vehicle or TCDD 
(1nM).  At the end of the 48 hour culture, the media were collected and assayed for 
levels of A4, T, E1, and E2.  TCDD exposure for 48 hours increased levels of A4 in the 
media, but did not change T, E1, and E2 levels compared to vehicle control (Fig 7 A-D).   
Previously, we measured hormone levels in the media for P, A4, T, and E2 after 
96 hours TCDD exposure, but did not measure E1 levels (Karman et al., 2012).  Thus, 
to test the hypothesis that TCDD alters E1 production/secretion after the longer 
exposure, antral follicles were cultured for 96 hours with vehicle or TCDD (1nM).  At the 
end of the 96 hour culture, the media were collected and assayed for levels of E1.  
TCDD did not significantly affect E1 levels in the media at 96 hours (Fig 8).  
 
Effect of TCDD exposure on the expression of transcript levels for key steroidogeneic 
enzymes in antral follicles 
To determine whether the decrease in sex steroid hormone levels observed in 
the follicle culture media after 96 hours TCDD exposure was due to altered/impaired 
regulation of genes responsible for cholesterol transport and/or genes for enzymes 
metabolizing cholesterol to the sex steroid hormones, follicles were collected at the end 
of the culture period and subjected to measurements of transcripts for Star, Cyp11a1, 
Cyp17a1, Hsd3b1, Hsd17b1, and Cyp19a1.  TCDD exposure did not alter the transcript 
levels for Star (Fig 9 A), but significantly decreased Cyp11a1, Cyp17a1, Hsd17b1, and 
Cyp19a1 transcript levels compared to controls (Fig 9 B, C, E and F).  Additionally, 
TCDD exposure increased Hsd3b1 transcript levels in antral follicles compared to 
controls (Fig 9 D).      
62 
 
         
Effect of TCDD on protein levels for key steroidogeneic enzymes in antral follicles 
Since proteins are ultimately the enzymes that catalyze metabolism of the sex 
steroid hormones, we compared protein levels for key steroidogenic enzymes from 
vehicle and TCDD exposed antral follicles after 48 hours.  We focused on CYP11A1 
because previously we were able to restore sex steroid hormone production/secretion 
by antral follicles exposed to TCDD with P5 co-treatment (Karman et al., 2012), 
suggesting TCDD affects upstream steroidogeneic enzymes.  Thus, we tested the 
hypothesis that TCDD exposure alters the protein levels for CYP11A1 because this 
enzyme is up-stream of P5 in the steroidogenic pathway.  After 48 hours, TCDD 
exposure did not change protein levels for CYP11A1 compared to vehicle (Fig 10 A and 
B).   
Since 48 hours TCDD exposure increased accumulation of the sex steroid 
hormone intermediate A4 in the media, we further hypothesized that TCDD exposure 
would increases conversion of DHEA to A4 via increased expression of the HSD3B1 
enzyme in antral follicles.  TCDD exposure for 48 hours did not change protein levels for 
HSD3B1 in antral follicles (Fig 10 E and F).   
Another possibility for the increased A4 levels in the media could be due to 
accumulation of this sex steroid hormone intermediate because of inhibition of 
downstream enzymes such as HSD17B1 and CYP19A1.  To test this hypothesis, we 
determined the effect of 48 hours exposure to vehicle or TCDD on HSD17B1 and 
CYP19A1 protein levels.  TCDD did not alter protein levels of HSD17B1 (Fig 11 A and 
B) or CYP19A1 (Fig 11 E and F) compared to vehicle exposed follicles. 
To determine whether the effects on these steroidogeneic enzymes by TCDD are 
time dependent, we compared their protein levels from vehicle and TCDD exposed 
antral follicles after the longer 96 hour exposure period.  TCDD did not significantly 
change protein levels of CYP11A1 (Fig 10 C and D), HSD3B1 (Fig 10 G and H), and 
CYP19A1 (Fig 11 C and D) compared to controls.  Interestingly, TCDD significantly 
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decreased protein levels for HSD17B1 compared to vehicle controls at 96 hours (Fig 11 
G and H). 
 
Effect of TCDD exposure on antral follicle atresia 
To determine whether the effects of TCDD exposure on antral follicle 
steroidogenesis are due to an ability of TCDD to kill antral follicles, antral follicles were 
collected at the end of the 48 and 96 hour cultures and evaluated for atresia.  TCDD 
exposure did not alter the level of atresia in antral follicles compared to controls at any 
time point (Fig 12 A - D).  Additionally, pyknotic bodies were only present in the antral 
space and not in the mural granulosa layer or in the thecal layer in both groups of 
follicles.  When the oocyte nucleus was present for evaluation, the germinal vesicle was 
intact, evidence that oocytes remained in meiotic arrest in both control and TCDD 
exposed antral follicles. 
 
Effect of TCDD exposure on the expression of the AHR protein in antral follicles 
Degradation of the AHR protein is considered a hallmark of its activation by 
ligands such as TCDD (Davarinos NA and Pollenz RS 1999;Pollenz RS 2002).  
Furthermore, the AHR is at the crossroads of toxicology and physiology because it has 
been identified as an important regulator of ovarian function and is activated by TCDD 
(Hernández-Ochoa I et al., 2009).  Thus, to determine if and when the AHR is activated 
in antral follicles by TCDD, antral follicles were cultured for either 48 or 96 hours with 
vehicle or TCDD (1nM).  At the end of the culture period, follicles were assayed by 
western blot for levels of AHR protein.  TCDD treatment resulted in down-regulation of 
the AHR protein in antral follicles after both 48 and 96 hours in vitro exposure (Fig 13 A 
and B). 
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3.5 Discussion 
 
 
The experimental results reported here and by others overwhelmingly support 
the hypothesis that TCDD exerts much of its toxicity directly on the ovary through 
inhibiting steroidogenesis, particularly at the level of the steroidogeneic enzymes.  To 
date, the majority of studies aimed at unraveling the mechanism of TCDD’s actions on 
steroidogenesis utilized isolated ovarian cells in culture.  Although the investigation of 
isolated ovarian cells has been a key to better understanding the mechanisms of TCDD 
toxicity in the ovary, isolated cells lack connections between the thecal and granulosa 
follicular cell types and are missing the oocyte compartment of the follicle necessary for 
proper functioning (Matzuk et al., 2002).  Previously, we demonstrated that an intact 
mouse antral follicle culture system is a valuable model for studying TCDD toxicity in the 
ovary (Karman et al., 2012).  The cultured follicles maintain much of their steroidogenic 
and proliferative capacity throughout the 96 hours culture period; maintaining the 
presence of granulosa cells, theca cells, a basement membrane and oocytes in meiotic 
arrest (Cortvrindt et al., 1997; Cortvrindt and Smitz 2002).  Thus, we used this culture 
system to examine the mechanism by which TCDD inhibits steroidogenesis.        
The first rate limiting step necessary for steroid synthesis in the antral follicle is 
the mobilization of cholesterol into the inner mitochondrial membrane via STAR.  
Previously, we were able to bypass the reduced steroidogenesis in TCDD exposed 
mouse antral follicles by co-culturing with P5, suggesting that TCDD could be inhibiting 
STAR (Karman et al., 2012).  Thus, in this study we hypothesized that TCDD exposure 
in vitro decreases levels of Star in antral follicles.  We did not find decreased levels of 
Star mRNA after 96 hours TCDD exposure in antral follicles, suggesting that the ability 
of TCDD to impair steroidogenesis is not through STAR.  Our results are similar to 
studies reporting that TCDD exposure did not alter the levels of Star mRNA in TCDD 
exposed rat granulosa cells (Hirakawa et al., 2008).   Additionally, TCDD did not change 
STAR protein levels even though it decreases Star mRNA in pubertal rat ovaries 
following embryonic and lactational TCDD exposures (Myllymäki et al., 2005; Pesonen 
et al., 2006).   
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Our results differ from studies investigating the adrenal and testis from rats 
exposed to TCDD and from studies examining the promoter activities of the human Star 
gene in adrenal tumor cells.  Specifically, it has been demonstrated that reduced 
steroidogenesis in the rat adrenal and testes from animals exposed to TCDD is primarily 
due to impairment of cholesterol transport, possibly via STAR (DiBartolomeis et al., 
1987; Moore et al., 1991).     Further, it was demonstrated in an adrenal tumor cell line 
transfected with a human Star promoter construct, that the Star gene is transcriptionally 
regulated by the ligand activated AHR (Sugawara et al., 2001).  It is possible that while 
Star may be a target for TCDD toxicity in various steroidogenic organs in the rat and 
human, it may not be in the mouse ovary.  Also, the systemic effects from in vivo TCDD 
studies could also explain some of the discrepancies between in vivo and in vitro 
studies.     
The next step in the steroidogenic pathway is conversion of cholesterol to P5 via 
CYP11A1.  To test the hypothesis that TCDD acts on the CYP11A1 enzyme in mouse 
antral follicles, we measured CYP11A1 mRNA and protein levels after 48 and 96 hours 
in vitro TCDD exposure in antral follicles.  TCDD significantly down regulated Cyp11a1 
mRNA after 96 hours, however, TCDD did not affect protein levels for CYP11A1 after 
both 48 and 96 hours exposure.  These results indicate that transcriptional AHR 
activation by TCDD ligand binding may regulate the Cyp11a1 gene expression.  Usually 
mRNA and protein levels correlate, but in this case, it could be that the western blot is 
not a sensitive enough method for detecting small changes in protein levels or the 
small, but significant changes observed in Cyp11a1 mRNA levels after 96 hours TCDD 
exposure are not enough to significantly lower the protein levels to a measurable 
amount.  It is likely that a longer and more chronic exposure to TCDD could cause 
decreases in CYP11A1 protein levels and activity in the antral follicle.    
Similar to our findings, one study conducted using FSH stimulated isolated rat 
granulosa cells found that Cyp11a1 mRNA levels were decreased after TCDD exposure 
(Dasmahapatra et al., 2000).  Also, juvenile post-natal day 16 rat ovaries had lower 
Cyp11a1 mRNA levels after in utero and lactational TCDD exposure (Myllymäki et al., 
2005). CYP11A1 is primarily expressed in the thecal cells of early antral follicles, but is 
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also expressed in the granulosa cells of preovulatory follicles and is stimulated there by 
FSH (Goldring et al., 1987).   In the current study, it is difficult to distinguish whether the 
thecal cells or the granulosa cells are a more sensitive target for the actions of TCDD on 
the CYP11A1 enzyme.    
To determine whether TCDD exposure impacts the conversion of P5 to DHEA or 
P4 to A4 under CYP17A1, we measured transcript levels for Cyp17a1 in antral follicles 
following 96 hours exposure.  TCDD significantly reduced Cyp17a1 levels in antral 
follicles.  This is consistent with studies conducted with human luteinized granulosa 
cells.  In those studies, Morán et al. demonstrated that the reduced steroidogenesis in 
human luteinized granulosa cells was the result of an impairment in the supply of 
androgens due to a decrease in the lyase activity of the CYP17A1 enzyme as well as 
decreased levels of CYP17A1 protein (Morán et al., 2003b; Morán et al., 2003a).     
HSD3B1 is responsible for isozyme conversion of P5 to P4, 17α-pregnenolone to 
17α-progesterone, and DHEA to A4.  Interestingly, we observed an increase in A4 
levels in the media after 48 hours antral follicle culture with TCDD.  This was followed 
by an increase in Hsd3b1 transcript levels and a major decrease in A4 levels by 96 
hours (Karman et al., 2012), indicating a possible rescue attempt by the TCDD exposed 
follicle to compensate for the reduced supply of hormone substrates (i.e. P4 or DHEA) 
due to decreased function of the upstream enzymes CYP11A1 and CYP17A1.  
Supportive of this idea, though it has been suggested that human luteinized granulosa 
cells have a super active HSD3B1 enzyme, the addition of DHEA to TCDD exposed 
cultured human luteinized granulosa cells restored E2 levels in the media to control 
levels (Morán et al., 2003a).  Interestingly, mouse antral follicles did not have altered 
levels of HSD3B1 protein after both 48 and 96 hours TCDD exposure, suggesting that 
this enzyme is not a major target for TCDD induced toxicity.   
The increase in A4 levels after 48 hours TCDD exposure could also be due to 
accumulation of this hormone substrate due to inhibited downstream enzymes such as 
CYP19A1 and HSD17B1.  HSD17B1 is an important enzyme because it is considered 
the major HSD17 enzyme involved in E2 synthesis in the rodent ovary and catalyzes 
the interconversion between the less active 17-oxosteroid and more active 17β-
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hydroxysteroid hormone forms.  In the mouse follicle, HSD17B1 is expressed in the 
granulosa cells of growing antral follicles and catalyzes the reduction of A4 to T and E1 
to E2 with equal efficiency (Ghersevich et al., 1994a; Nokelainen et al., 1996).  Thus, 
we tested the hypothesis that TCDD exposure affects expression of the HSD17B1 
enzyme in antral follicles.  We found that TCDD exposure significantly reduced both 
transcript and protein levels for HSD17B1 in antral follicles after 96 hours exposure, 
while there was no change in the protein levels after only 48 hours exposure.  These 
data suggest that actions of TCDD on the HSD17B1 enzyme are time dependent and 
may follow a reduction in A4, T and E2 as well as a reduction in cAMP.  In rats, 
HSD17B1 is primarily regulated by FSH and modulated by sex steroid hormones and 
growth factors in the follicle (Ghersevich et al., 1994a; Ghersevich et al., 1994b).  
Specifically, FSH stimulates HSD17B1 expression through a protein kinase A-
dependent pathway in isolated rat granulosa cells (Ghersevich et al., 1994b).  
Additionally, estrogens and androgens enhance the stimulatory effects of FSH on 
HSD17B1 expression and activity (Ghersevich et al., 1994a).  Though we did not 
measure cAMP or growth factor levels in TCDD exposed antral follicles, we did observe 
that E2 and T levels in the media were not altered after 48 hours TCDD exposure when 
HSD17B1 protein levels were unaffected.  HSD17B1 transcript and protein levels were 
only affected after longer TCDD exposure when E2 and T levels were significantly 
down.  Since both transcript and protein levels for HSD17B1 were significantly affected 
by TCDD exposure, it is likely that this enzyme plays a more important role in mouse 
follicle steroidogenesis and is a major target for ovarian toxicity when compared to 
CYP19A1.  To our knowledge, this is the first report on the actions of TCDD on the 
HSD17B1 enzyme.   
The effects of TCDD on the CYP19A1 enzyme in the ovary have been more 
extensively studied than the effects of TCDD on other steroidogeneic enzymes.  Like 
HSD17B1, CYP19A1 is located in the granulosa cells of antral follicles and is primarily 
regulated by FSH, sex steroid hormones, and growth factors (Stocco 2008).  It is the 
enzyme responsible for aromatizing A4 to E1 and T to E2 in the ovary.  TCDD did not 
significantly alter the levels of E1 after 48 hours exposure, but caused a non-significant 
decrease after 96 hours.  The slight decrease in E1 levels after 96 hours suggests that 
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TCDD could be targeting the CYP19A1 enzyme in the mouse antral follicle.  Thus, we 
tested the hypothesis that TCDD exposure affects CYP19A1 transcript and protein 
levels in mouse antral follicles.  Interestingly, TCDD exposure decreased Cyp19a1 
transcript levels after 96 hours, but there was no effect on protein levels after both 48 
and 96 hours exposure.  Similarly, studies conducted by Dasmahapatra et al. using 
FSH-stimulated rat granulosa cells exposed to TCDD, found that the addition of A4 
partially restored E2 levels, suggesting actions on both CYP19A1 and HSD17B1 
enzymes.  Although they did not measure HSD17B1, upon further investigation, 
Dasmahapatra et al. found that TCDD inhibited the FSH-stimulated increase in 
CYP19A1 mRNA levels and enzyme activity usually exhibited by these cells, indicating 
possible actions on this enzyme as well as the follicle stimulating hormone receptor 
(Dasmahapatra et al., 2000).  Gregoraszczuk also found evidence of reduced CYP19A1 
activity in porcine granulosa and thecal cell co-cultures after TCDD exposure 
(Gregoraszczuk 2002).  Further, Myllymäki et al. found decreased Cyp19a1 mRNA 
levels in pubertal ovaries and decreased CYP19A1 enzyme activity in isolated follicles 
from rats exposed in utero and lactationally to TCDD (Myllymäki et al., 2005).  Although 
transcript levels were not assayed, similar to our findings for CYP19A1, protein levels 
were unaffected in human luteinized granulosa cells (Morán et al., 2000).  While another 
environmental toxicant dimethylbenzanthracene (DMBA) has been shown to enhance 
the transcription of Cyp19a1 in the mouse ovary through AHR binding to an AHRE in 
the ovary specific Cyp19a1 gene promoter, it is possible that TCDD could have the 
opposite effect and repress the promoter activities of this gene leading to a decrease in 
E2 synthesis (Baba et al., 2005).   
TCDD has been identified as both an inducer and a suppressor of programmed 
cell death (apoptosis) depending on the tissue or the experimental model(Chopra and 
Schrenk 2011) (Puga et al., 2009).  Apoptosis is a normal process in the ovary, is 
hormonally regulated, and is responsible for elimination of   >95% of the follicles from 
the ovary by the time of reproductive senescence (Kaipia and Hsueh 1997).  Thus, we 
hypothesized that TCDD exposure alters the amount of apoptosis in the antral follicle in 
vitro.  TCDD exposure did not alter the amount of apoptosis in antral follicles compared 
to vehicle treated follicles after both 48 and 96 hours exposure.  These results suggest 
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that TCDD does not increase apoptosis of antral follicles, which is consistent with the 
findings from in vivo studies in rats, but is contrary to the findings in human luteinized 
granulosa cells.  Specifically, rats gestationally exposed to TCDD had fewer large 
preantral and early antral follicles with no difference in the level of apoptotic cell death 
or atresia ratings when compared to vehicle control treated rats (Heimler et al., 1998b).  
Another study found that TCDD induced apoptosis in human luteinized granulosa cells 
in a dose and time dependent manner (Heimler et al., 1998a).  The effects seen in 
human luteinized granulosa cells could be due to the higher doses of TCDD that were 
employed or due to the endocrine status of the donor cells from infertility patients.  The 
highest dose of TCDD (3.1μM) also resulted in an increase in E2 levels in the media 
from exposed human luteinized granulosa cells, which was attributed to possible 
changes in membrane permeability due to the observation that the TCDD exposed 
human luteinized granulosa cells had extracellular DNA, not membrane enclosed, as 
examined via transmission electron microscopy techniques.    
Finally, it has been proposed that TCDD primarily acts through the AHR to elicit 
toxicity in the ovary.  The AHR has been identified as an important factor that mediates 
steroidogenesis and hormone signaling in the ovary.  In pigs and primates, the AHR is 
expressed in all follicle cell types, but particularly in the granulosa cells (Baldridge and 
Hutz 2007; Wojtowicz et al., 2005).  Levels of the AHR change in the ovary with the 
reproductive cycle, and FSH and E2 are modulators of AHR expression (Bussmann and 
Baranao 2006; Chaffin et al., 1999; Chaffin et al., 2000).  Besides FSH and E2, multiple 
cellular factors and processes have been identified that alter AHR levels and activity in 
various tissues (Harper et al., 2006).  It has been suggested that LH may be a regulator 
of AHR transcriptional activity in the ovary by inducing the aryl hydrocarbon receptor 
repressor (AHRR) (Baba et al., 2005).  Furthermore, antral follicles from AHR -/- 
females produce less E2 and their ovaries express lower levels of Cyp19a1 mRNA 
without an increase in antral follicle atresia compared to wild type mice (Baba et al., 
2005; Barnett et al., 2007; Benedict et al., 2003).  
Also, there is evidence supporting the hypothesis that the proteolytic degradation 
of the AHR protein could be one mechanism for attenuating AHR-mediated gene 
regulation (Pollenz et al., 2005).   Thus, since we observed down regulation of the AHR 
70 
 
protein after both 48 and 96 hours TCDD exposure, and a rise in Cyp1b1 mRNA levels 
in antral follicles (Karman et al., 2012), it is possible that a ubiquitin-proteasome 
pathway is active in the ovary as well as recruitment of the AHR to the Cyp1b1 
promoter.   Similar to our findings, Bussmann et al. demonstrated the rapid proteasomal 
degradation of the AHR after ligand exposure in rat granulosa cells (Bussmann and 
Baranao 2006).  More specifically they found that the degradation occurred as early as 
4 hours after β-naphthoflavone exposure and inhibiting proteasomal degradation with a 
chemical inhibitor caused a super-induction of the Cyp1a1 gene.  They also observed a 
rise in AHR mRNA levels after 48 hours β-naphthoflavone exposure.  TCDD exposure 
did not result in significant changes in AHR mRNA levels after 96 hours in mouse antral 
follicles (Karman et al., 2012).  The differences between the two studies could be due to 
the higher stability of TCDD when compared to other AHR ligands such as β-
naphthoflavone, repressing the AHR protein and maintaining constant mRNA levels for 
longer periods (Pollenz 2002).  
In conclusion, the direct actions of TCDD on the ovary appear to be primarily on 
the steroidogenic enzymes leading to reduced steroidogeneic capacity of antral follicles 
without affecting atresia.  Evidence reported here and by others indicates that TCDD 
acts mainly on the granulosa cells, evidenced by its major effects on HSD17B1 and 
CYP19A1.  This is the first report of the actions of TCDD on the HSD17B1 enzyme in 
the ovary.  Transcriptional AHR activation by TCDD and other ligands may lead to 
proteasomal degradation and chronic down regulation of the protein in the antral follicle.  
This chronic down-regulation may dampen the toxic response pathway, rescuing the 
follicle from death, but also could cause deregulation of the endogenous actions of the 
AHR protein in the ovary.  Future studies should be targeted at understanding the 
mechanisms of endogenous AHR function in the ovary and the consequences of 
exogenous ligand binding to this receptor.  
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     3.6 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7 
Effect of 48 hours TCDD exposure on A4, E1, T, and E2 production/secretion by antral 
follicles in vitro.  Antral follicles were mechanically isolated from young cycling CD1 
mice and exposed for 48 hours in culture to TCDD (1nM) or vehicle alone.  After the 48 
hour culture period, media were collected and subjected to hormone assays for (A) 
androstenedione, (B) estrone, (C) testosterone, and (D) estradiol levels.  The graphs 
represent the mean hormone levels ±SEM from 8-16 culture wells from four separate 
follicle culture experiments.   Column with an asterisk (*) is significantly different from 
the vehicle control (p≤0.05). 
* 
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Fig 8 
Effect of 96 hours TCDD exposure on E1 production/secretion by antral follicles in vitro.  
Antral follicles were mechanically isolated from young cycling CD1 mice and exposed 
for 96 hours in culture to TCDD (1nM) or vehicle alone.  After the 96 hour culture period, 
media were collected and subjected to hormone assays for estrone.  The graph 
represents the mean hormone levels ±SEM from 12 culture wells from four separate 
follicle culture experiments.    
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Fig 9 
Effect of 96 hours in vitro TCDD exposure on the expression of steroidogenic enzyme 
transcripts in antral follicles.  At the end of each of the 96 hour cultures, 8-16 follicles 
from each treatment group were pooled and immediately snap frozen in liquid nitrogen 
and assayed by real time qPCR for levels of (A) Star (B) Cyp11a1, (C) Cyp17a1, (D) 
Hsd3b1, (E) Hsd17b1, and  (F) Cyp19a1.  Levels of these key steroidogeneic enzymes 
were normalized to β-actin (Actb). Data are expressed as mean relative expression 
ratios ± SEM calculated from 3 - 4 separate culture experiments.  Columns with 
asterisks indicate * p≤0.05, ** p≤0.01, ***p≤0.001.    
  
  
* 
Hsd3b1 
* 
Star Cyp11a1 
* 
Cyp17a1 
** 
Hsd17b1 
*** 
Cyp19a1 
A B C 
D E F 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10 
Effect of 48 and 96 hours in vitro TCDD exposure on CYP11A1 and HSD3B1 protein 
expression in antral follicles.  At the end of each of the cultures, 12-16 follicles from 
each treatment group were pooled and immediately snap frozen in liquid nitrogen and 
analyzed by western blot for CYP11A1 (A-D) and HSD3B1 (E-H) protein levels.    Antral 
follicles (250-350 μm) (F), ovary (O), heart (H), lung (L), and a biopsy of skeletal muscle 
(M) were removed from a PND 33 female mouse and analyzed as positive and negative 
controls.  Densitometric units of the CYP11A1 and HSD3B1 protein bands were 
normalized to the densitometric units of the corresponding ACTB protein bands on each 
blot for quantification.  Data are expressed as mean relative expression ratios ± SEM 
calculated from four separate culture experiments (graphs A and E represent the 48 
hour cultures and graphs C and G represent the 96 hour cultures).  B, D, F, and H are 
representative images of the protein bands from western blots for CYP11A1 and 
HSD3B1 with an image of the corresponding ACTB protein bands that were used as 
loading controls below.  V = vehicle control, T = 1nM TCDD, and X = blank lane.    
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Fig 11 
Effect of 48 and 96 hours in vitro TCDD exposure on HSD17B1 and CYP19A1 protein 
expression in antral follicles.  At the end of each of the cultures, 12-16 follicles from 
each treatment group were pooled and immediately snap frozen in liquid nitrogen and 
analyzed by western blot for HSD17B1 (A-D) and CYP19A1 (E-H) protein levels.    
Antral follicles (250-350 μm) (F), ovary (O), heart (H), lung (L), and a biopsy of skeletal 
muscle (M) were removed from a PND 33 female mouse and analyzed as positive and 
negative controls.  Densitometric units of the HSD17B1 and CYP19A1 protein bands 
were normalized to the densitometric units of the corresponding ACTB protein bands on 
each blot for quantification.  Data are expressed as mean relative expression 
ratios ± SEM calculated from four separate culture experiments (graphs A and E 
represent the 48 hour cultures and graphs C and G represent the 96 hour cultures).  B, 
D, F, and H are representative images of the protein bands from western blots for 
HSD17B1 and CYP19A1, with an image of the corresponding ACTB protein bands that 
were used as loading controls below.  V = vehicle control, T = 1nM TCDD, and X = 
blank lane.     
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Fig 12 
Effect of 48 and 96 hours in vitro TCDD exposure on atresia in antral follicles.  At the 
end of each follicle culture experiment, supplemented α-MEM was removed from each 
well and Dietrich’s solution was immediately added to fix the follicles.  The tissues were 
dehydrated, embedded in cold-curing plastic resin, serially sectioned (2μm), mounted 
on charged glass slides, stained and analyzed for atresia rating.  All analyses were 
conducted without knowledge of treatment group. Ratings were averaged and plotted to 
compare the effect of TCDD on atresia levels.  Graphs represent the mean atresia 
rating for each follicle section examined from 8-10 follicles per treatment group from 4 
separate follicle culture experiments ± SEM.    A = graph for atresia ratings and B = 
representative (10X) microscope images of antral follicle sections from follicles exposed 
for 48 hours to DMSO or TCDD.  C = graph for atresia ratings and D = representative 
(10X) light microscope images of antral follicle sections from follicles exposed for 96 
hours to DMSO or TCDD.  
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Fig 13 
Effect of 48 and 96 hours in vitro TCDD exposure on AHR protein expression in antral 
follicles.  At the end of each of the cultures, 12-16 follicles from each treatment group 
were pooled and immediately snap frozen in liquid nitrogen and analyzed by western 
blot for AHR protein levels.  Antral follicles (250-350 μm) (F), ovary (O), heart (H), lung 
(L), and a biopsy of skeletal muscle (M) were removed from a PND 33 female mouse 
and analyzed as positive controls.  Densitometric units of the AHR protein bands were 
normalized to the densitometric units of the corresponding ACTB protein bands on each 
blot for quantification.  Data are expressed as mean relative expression ratios ± SEM 
calculated from four separate culture experiments.    Graph A represents the 48 hour 
cultures and graph C represents the 96 hour cultures.  B and D are representative 
images of the protein bands from western blots for AHR with an image of the 
corresponding ACTB protein bands that were used as loading controls below.  V = 
vehicle control, T = 1nM TCDD, and X = blank lane.  Columns with asterisks indicate * 
p≤0.05 and ***p≤0.001. 
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Table 1 
Transcript 
NCBI 
reference 
sequence Forward primer sequence 5’- 3’ Reverse primer sequence 5’- 3’ 
Actb NM_007393.3 GGG CAC AGT GTG GGT GAC CTG GCA CCA CAC CTT CTA C 
Star NM_011485.4 CAG GGA GAG GTG GCT ATG CA CCG TGT CTT TTC CAA TCC TCT G 
Cyp11a1 NM_008841.2 AGA TCC CTT CCC CTG GTG ACA ATG CGC ATG AGA AGA GTA TCG ACG CAT C 
Cyp17a1 NM_007809.3 CCA GGA CCC AAG TGT GTT CT CCT GAT ACG AAG CAC TTC TCG 
Hsd3b1 NM_008293.3 CAG GAG AAA GAA CTG CAG GAG GTC GCA CAC TTG CTT GAA CAC AGG C 
Hsd17b1 NM_010475.1 CTG CCA TTC CAC GAA GTG TAC TGT TTG CTC ATA ACC ACG CAG GTA GTG 
Cyp19a1 NM_007810.3 CAT GGT CCC GGA AAC TGT GA GTA GTA GTT GCA GGC ACT TC 
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Chapter IV: In vitro TCDD exposure inhibits Bax and possibly decreases the capacity to 
inactivate reactive estrogen metabolites in antral follicles 
 
4.1 Abstract 
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent ovarian toxicant.  Previously, we 
demonstrated that in vitro TCDD (1nM) exposure decreases production/secretion of sex 
steroid hormones such as 17β-estradiol (E2) and down regulates the AHR protein 
without altering atresia in mouse antral follicles.  In the granulosa cells of healthy antral 
follicles, E2 acts with other factors to suppress transcription of proapototic factors such 
as BCL2-associated X protein (Bax).  B cell leukemia/lymphoma 2 (Bcl2) acts to 
suppress the actions of Bax.  Also, TCDD and the AHR have been identified as both 
inducers and suppressors of apoptosis by altering levels of Bax, depending on the 
tissue and the experimental model.  Since TCDD did not induce atresia in antral 
follicles, we wanted to further explore the intracellular signaling pathway for apoptosis in 
antral follicles following TCDD exposure.  To do so, we examined the effects of TCDD 
on levels of Bcl2 and Bax.  TCDD exposure for 96 hours decreased levels of Bax 
transcript, but it did not change the levels of Bcl2.  Additionally, we previously 
demonstrated that cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1) 
levels were increased in antral follicles following TCDD exposure.  Cyp1b1 is an 
important enzyme that is implicated in both biotransformation of TCDD and also in E2 
catabolism to catecholestrogens and the highly reactive quinones.  Quinones are known 
to cause DNA damage, and if the DNA is left unrepaired, it can lead to mutations that 
propagate into daughter cells, leading to cancer.  Besides its effects on E2 levels, 
chronic TCDD exposure causes promotion of ovarian tumors in rats and acute exposure 
is associated with an increased incidence of ovarian cancer in young woman.  The 
enzyme catechol-o-methyltransferase (COMT) is regulated by E2 and is an important 
enzyme for inactivating the catecholestrogens.  Thus, we hypothesized that TCDD 
exposure affects the levels of COMT.  TCDD exposure reduced COMT protein levels, 
while there was no change in transcript levels for COMT after 96 hours exposure in 
antral follicles.  Overall, these data indicate that TCDD exposure perturbs two 
mechanistically different processes in the ovary, which are involved in the balance of 
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apoptosis and survival in the ovary.  These two mechanistically distinct actions of TCDD 
on the ovary could collectively contribute to ovotoxicity, endocrine disruption, and 
cancer promotion. 
 
 
4.2 Introduction 
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic member of a class 
of chemicals called dioxins and is a persistent contaminant found in the human food 
chain, in the waterways, and in the air due to industrial waste (Birnbaum and DeVito 
1995; Frakes et al., 1993; Hites 2011; Tuppurainen et al., 2003).  TCDD has a long half-
life in the body and can remain in humans for more than 10 years after a single 
exposure due to its highly lipophilic nature, slow metabolism, and slow excretion 
(Miniero et al., 2001; Sorg et al., 2009).  Dioxins, like TCDD, have been detected in 
human fat tissue, blood serum, breast milk, and ovarian follicular fluid (Birnbaum and 
DeVito 1995; Humblet et al., 2011; Schecter et al., 2006; Tsutsumi et al., 2011; 
Ulaszewska et al., 2011).  TCDD is an endocrine disruptor, cancer promoter, and potent 
ovarian toxicant.   
Previously, we demonstrated that in vitro TCDD (1nM) exposure decreases 
production/secretion of sex steroid hormones such as 17β-estradiol (E2) and down 
regulates the AHR protein without altering atresia in mouse antral follicles (Chapters II 
and III).  E2 is an important survival factor that helps to protect follicles from apoptosis 
(Kaipia and Hsueh 1997).  It has been demonstrated that atresia caused by other 
environmental contaminants is primarily through apoptosis and not via other forms of 
cell death, such as necrosis (Matikainen et al., 2001; Pru et al., 2009; Springer et al., 
2012; Takai et al., 2003).  Furthermore, the AHR is at the crossroads of toxicology and 
physiology because it has been identified as an important regulator of ovarian function 
and is activated by TCDD in the ovary (Hernández-Ochoa et al., 2009).   
The endogenous functions of the AHR and its role in toxicology are complex.  
TCDD and the AHR have been identified as both inducers and suppressors of apoptosis 
depending on the tissue, the experimental model, or dose and length of TCDD 
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exposure.  Specifically, TCDD has been shown to induce apoptosis in thymocytes, but 
to inhibit apoptosis in liver cells (Chopra et al., 2009; Kamath et al., 1997; Worner and 
Schrenk 1996; Wörner and Schrenk 1998).  Further, studies investigating the effects of 
TCDD exposure on human lutenized granulosa cells found that apoptosis was induced 
in a time and dose dependent manner (Heimler et al., 1998).  
 Apoptosis is a normal process in eukaryotic cells and is important for eliminating 
damaged or unwanted cells (Kerr et al., 1972).  Disruption of mitochondrial membrane 
integrity by altering expression of bcl-2 proto-oncogene gene family members such as B 
cell leukemia/lymphoma 2 (Bcl2) and BCL2-associated X protein (Bax), is one pathway 
known to initiate apoptosis.  Bax is known to promote apoptosis by compromising 
mitochondrial membrane integrity, causing release of cytochrome c and activation of the 
caspases, while other factors such as Bcl2 help to maintain mitochondrial membrane 
integrity (Danial and Korsmeyer 2004).  An imbalance of either Bcl2 or Bax could be an 
indication of a cell under stress and altered expression of these factors has been 
identified in some cancers (Christensen et al., 1999).    
TCDD exposure in mice has been shown to act through the AHR to increase 
levels of the proapoptotic gene Bax in the thymus, contributing to apoptosis (Camacho 
et al., 2005; Fernandez-Salguero et al., 1996; Zeytun et al., 2002).  TCDD is considered 
a liver tumor promoter and acts primarily through the AHR, as AHR -/- mice are 
resistant to the effects of TCDD (Fernandez-Salguero et al., 1996;Pitot et al., 1980).  In 
liver cells, TCDD exposure does not alter the expression of Bcl2 or Bax and inhibits 
apoptosis in liver cells undergoing programmed cell death due to ultraviolet light 
treatment (Chopra et al., 2009; Worner and Schrenk 1996).   Also, a functional aryl 
hydrocarbon receptor response element (AHRE) was identified in the Bax promoter 
(Matikainen et al., 2001).  It was demonstrated that a metabolite of 9,10-
dimethylbenz[a]anthracene (DMBA) and not TCDD, induced increased transcription of 
Bax through this AHRE in oocytes transfected with a Bax promoter-GFP reporter 
construct (Matikainen et al., 2001).  Collectively, these experimental results suggest 
AHR ligand and tissue specific action on Bax promoter activities.   
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Thus, because E2 production/secretion and AHR levels are dramatically reduced 
without inducing atresia in TCDD exposed mouse antral follicles, we hypothesized that 
the intracellular signaling pathway for apoptosis is altered, resulting in an environment 
that favors survival over death.  To test this hypothesis we examined the effects of 
TCDD on the expression of Bcl2 and Bax in antral follicles.   
Another pathway known to impact cell death and survival in the ovary is the 
production of reactive metabolites by the cytochrome P450 phase I enzymes and 
deactivation of those metabolites by phase II enzymes.  We previously demonstrated 
that in vitro TCDD exposure increases cytochrome P450, family 1, subfamily b, 
polypeptide 1 (Cyp1b1) levels in antral follicles (Karman et al., 2012).  Cyp1b1 is an 
important enzyme that is implicated in both biotransformation of TCDD and also in E2 
catabolism to catecholestrogens and the highly reactive quinones (Badawi et al., 2001; 
Bhattacharyya et al., 1995; Hayes et al., 1996; Otto et al., 1992; Parl et al., 2009).  
Quinones are known to cause DNA damage, and if the DNA is left unrepaired it can 
lead to mutations that propagate into daughter cells leading to cancer (Parl et al., 2009).  
Chronic TCDD exposures cause promotion of ovarian tumors in rats and acute 
exposure is associated with an increased incidence of ovarian cancer in young woman 
(Davis et al., 2000; Pesatori et al., 1993).  The enzyme catechol-o-methyltransferase 
(COMT) is regulated by E2 and is an important enzyme for inactivating the 
catecholestrogens (Schendzielorz et al., 2011).  Thus, we hypothesized that TCDD 
exposure would affect the COMT enzyme.  To test this hypothesis, we examined the 
effects of TCDD on the mRNA expression and protein levels of COMT in antral follicles.   
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4.3 Materials and methods 
 
Chemicals 
TCDD dissolved in dimethyl sulphoxide (DMSO) at 50μg/mL (#ED-901-B) was 
purchased from Cambridge Isotope Laboratories, Inc., Andover, MA. DMSO (D2650), 
100X insulin, transferrin, and selenium (ITS), penicillin and streptomycin were 
purchased from Sigma-Aldrich (St. Louis, MO).  Alpha minimal essential media (α-MEM) 
was purchased from Invitrogen (Carlsbad, CA).  Fetal bovine serum (FBS) was 
purchased from Atlanta Biologicals, Lawrenceville, GA.  Human recombinant follicle-
stimulating hormone (hFSH) was obtained from Dr. A. F. Parlow, National Hormone and 
Peptide Program, Harbor-UCLA Medical Center, Torrance, CA.   
 
Animals 
CD-1 mice were purchased from Charles River and maintained in accordance 
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, 
and all protocols were approved by the University of Illinois Animal Care and Use 
Committee.  Upon arrival to the University of Illinois animal care facility, mice were 
allowed to acclimate for a minimum of 48 hours prior to tissue collection.  All mice were 
housed under strict 12L:12D lighting and temperature was maintained at 22±1ºC.  Food 
and water were provided ad libitum. 
 
In vitro mouse antral follicle culture 
Female mice were euthanized by CO2 asphyxiation followed by cervical 
dislocation on postnatal day (PND) 33 and their ovaries were removed.  Small antral 
follicles were isolated mechanically from the ovaries of 2-4 mice for each experiment 
based on relative size (250-350μm) and cleaned of interstitial tissue using ﬁne #5 
watchmaker forceps in unsupplemented α-MEM.  Approximately 20–30 antral follicles 
were isolated from each mouse.  Follicles were then placed randomly one per individual 
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well in a 96-well culture plate with α-MEM prior to treatment.  For each experiment, a 
minimum of eight follicles were plated per treatment group.  Supplemented α-MEM was 
prepared with 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 ng/ml selenium), 100 
U/ml penicillin, 100 μg/ml streptomycin, 5 IU/ml hFSH, and 5% FBS.  TCDD or vehicle 
alone was added to the supplemented α-MEM at an equal volume (0.75μL/mL media) to 
maintain the vehicle concentration at a constant of 0.075% for each treatment.  For 
treatment, unsupplemented α-MEM was removed from each well and replaced with 
150μL of supplemented α-MEM containing vehicle or 1nM TCDD.  We elected to use 
1nM TCDD because this environmentally relevant dose significantly affected sex steroid 
hormone production/secretion in antral follicles in a previous study (Karman BN et al., 
2012).  Follicles were then incubated for either 48 or 96 h at 37ºC in 95% air and 5% 
CO2. 
 
Analysis of Bcl2, Bax, and Comt transcripts  
At the end of the cultures, 8-16 follicles from each treatment group were pooled 
and immediately snap frozen in liquid nitrogen and stored at -80ºC until quantitative real 
time PCR (qPCR) analysis.  Total RNA was extracted using the RNeasy Micro Kit with 
DNase treatment to eliminate potential genomic DNA contamination according to the 
manufacturer’s instructions (Qiagen, Valencia, CA).  Concentration, purity, and quality 
of the RNA were determined using the NanoDrop ND-1000 UV-Vis spectrophotometer 
at 260 nm and 280 nm (Nanodrop Technologies, Wilmington, DE).  Total RNA (250ng) 
was reverse transcribed using an iScript cDNA synthesis kit according to manufacturer’s 
instructions (Bio-Rad, Hercules, CA).  Negative controls included omission of reverse 
transcriptase and omission of template.  Each of the final cDNA samples were then 
diluted 1:4 for real time qPCR analysis. 
 All qPCR reactions were performed in triplicate using the CFX96 Real-time 
System C1000 Thermal Cycler (Bio-Rad).  Each qPCR reaction contained 5μL of 2X 
SsoFastTM Evagreen® supermix, 0.6μL of gene specific primers, 2.4μL of nuclease free 
water, and 2μL of diluted cDNA template.  The final concentration for each gene specific 
primer in the qPCR reactions was 0.3pmoles/ μL.  A BLASTN search was performed in 
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GenBank to ensure that all primers were unique to the gene of interest. To avoid 
amplification from genomic DNA contamination, all primer sets spanned a large exon-
intron-exon junction.  Primer sequences are shown in table 2.  Initial denaturation of the 
cDNA and enzyme activation occurred at 95ºC for 1 min, followed by 40 cycles of (10 
seconds at 95ºC, 10 seconds at 60ºC, and a fluorescent absorbance reading), and one 
final annealing/elongation step for 5 minutes at 72ºC.  A heat dissociation curve (from 
65ºC-95ºC with a fluorescent absorbance reading after each 0.5ºC increment) was 
performed at the end of every run to assure specificity of each primer pair for the 
chosen transcript of interest.  
 For relative quantification of transcript levels, standard curves were generated 
using a six step serial dilution of cDNA generated from pooled RNA samples for each 
primer set being used.  These standard curves were used to calculate the amplification 
efficiencies for each primer pair.  Relative transcript amount was then calculated by a 
mathematical model developed by Pfaffl (Pfaffl MW 2001).  Briefly, the method involves 
calculating the relative expression ratio of the target gene based on the amplification 
efficiency of each amplicon and the ΔCt of the treated samples versus the vehicle 
control.  These ratios were then compared to the expression of the reference gene β-
actin (Actb).  Actb was verified as a good internal control because its levels were 
unchanged with treatment (data not shown).  The data were reported as mean transcript 
expression ratios relative to Actb from 3-4 separate follicle culture experiments.   
 
 
Analysis of COMT protein levels 
At the end of each of the cultures, 12-16 follicles from each treatment group were 
pooled and immediately snap frozen in liquid nitrogen and stored at -80ºC until analysis 
by western blot.  The pooled follicles were then lysed and homogenized in 20 μl T-Per 
(Thermo Fisher Scientific, Rockford, IL) containing protease inhibitors (Roche 
Diagnostics, Mannheim, Germany).  For positive controls, a PND 33 female mouse was 
euthanized as previously described and the ovaries, heart, lung, and skeletal muscle 
were removed and immediately snap frozen and stored at -80ºC until analysis by 
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western blot.  Tissues were lysed and homogenized in T-Per containing protease 
inhibitors according to manufacturer’s instructions. After tissue lysis, homogenization, 
and centrifugation, the protein concentration in the supernatant was determined by 
using a bicinchoninic acid (BCA) assay kit (Thermo Fisher Scientific, Rockford, IL). 
Electrophoresis and immunoblotting were performed using XCell SureLock Mini-Cell 
Blot Module Kit and recommended reagents as per manufacturer's protocol (Invitrogen, 
Carlsbad, CA).  
The protein lysate (2 μg) was loaded on precast 4–12% bis-tris sodium dodecyl 
sulfate-polyacrylamide gels (SDS-PAGE; Invitrogen, Carlsbad, CA), followed by transfer 
of the proteins to 0.45μm InvitralonTM polyvinylidene difluoride membranes (Invitrogen, 
Carlsbad, CA) at 4 °C. The blots were blocked with 5% non-fat milk for one hour at 
room temperature and then incubated overnight at 4 °C with primary antibody.  The 
primary antibody for COMT 611970 was used at 1:10,000 (BD Biosciences, San Jose, 
California).  After three washes, the membranes were incubated for one hour at room 
temperature with horseradish peroxidase conjugated anti-mouse secondary antibody 
(A9044) at 1:4000 (Sigma, Saint Louis, MO).  To ensure uniform loading of the proteins, 
the blots were incubated with the anti-beta actin antibody (ACTB) ab8227 diluted 1:5000 
(Abcam Inc., Cambridge, MA), followed by horseradish peroxidase conjugated goat 
anti-rabbit ab6721 secondary antibody diluted 1:5000 (Abcam Inc., Cambridge, MA).  
The immune complexes on the blots were visualized using an enhanced 
chemiluminescence detection kit (Cell Signaling Technologies, Danvers, MA) and 
captured on X-ray film. Scanning densitometry using the Image J software downloaded 
from the NIH website (http://rsb.info.nih.gov/ij/) was used to compare the protein levels. 
Specifically, densitometric units of the COMT protein bands were normalized to the 
densitometric units of the corresponding β-actin (ACTB) protein bands on each blot for 
quantification. 
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Statistical Analysis 
Independent samples t-tests were used to analyze the data.  If the data did not 
pass the assumption of homogeneity of variance, the non-parametric Mann-Whitney U 
test was employed.  Statistical significance was assigned at p≤0.05 for all comparisons.  
All data were analyzed using SPSS 11.0 statistical software (SPSS Inc., Chicago, IL). 
 
4.4 Results 
  
Effect of TCDD exposure on the expression of Bcl2 and Bax transcript levels  
To determine whether TCDD exposure impairs expression of genes responsible 
for apoptosis, follicles were collected at the end of the culture period and subjected to 
measurements of transcripts for the anti-apoptotic factor Bcl2 and the proapoptotic 
factor Bax.  TCDD exposure did not alter the transcript levels for Bcl2 (Fig 14 A), but 
significantly decreased Bax (Fig 14 B) transcript levels compared to controls.  
 
 
Effect of TCDD exposure on the expression of COMT mRNA in antral follicles 
The enzyme catechol-o-methyltransferase (COMT) is regulated by E2 and is an 
important enzyme for inactivating the catecholestrogens (Schendzielorz N et al., 2011).  
To determine whether TCDD affects Comt mRNA levels, we compared the expression 
of Comt mRNA in antral follicles treated with vehicle or TCDD for 96 hours.  At the end 
of the culture period, follicles were assayed by real time quantitative PCR (qPCR) for 
the Comt transcript.  TCDD treatment did not alter transcript levels for Comt compared 
to controls (Fig 15). 
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Effect of TCDD exposure on the expression of COMT protein in antral follicles 
Proteins are ultimately the enzymes that catalyze the metabolism of the 
catacholestrogens.  Thus, we hypothesized that TCDD exposure would affect COMT 
protein levels.  To test this hypothesis, we examined the effects of TCDD on the 
expression of COMT protein in antral follicles.  TCDD treatment resulted in a small, but 
significant down-regulation of the COMT protein in antral follicles after both 48 and 96 
hours in vitro exposure (Fig 16 A-D).  All of the tissues examined had both a soluble and 
microsomal membrane form of COMT, with the soluble form predominating in the heart, 
lung and whole ovary.  The antral follicle had equal amounts of both microsomal 
membrane and soluble forms of COMT.  TCDD exposure did not alter the ratio these 
two forms. 
 
 
4.5 Discussion 
 
In the granulosa cells of healthy antral follicles, E2 acts with other factors to 
suppress transcription of proapototic factors such as Bax (Matsuda F et al., 2012).  Bcl2 
acts to suppress the actions of Bax.  Previously, we reported that E2 and AHR levels 
are significantly reduced without an increase in atresia in antral follicles following TCDD 
exposure.  In other studies, both E2 and AHR have been implicated in modulating 
apoptosis through the Bcl2 family members in the ovary.  Thus, we hypothesized that 
TCDD alters the ratio of Bcl2 and Bax, favoring survival over death in the follicle (Hu et 
al., 2001; Kaipia and Hsueh 1997; Kee et al., 2010; Matikainen et al., 2001; Springer et 
al., 2012; Takai et al., 2003; Thompson et al., 2005).  To test this hypothesis, we 
measured levels of Bcl2 and Bax in antral follicles following TCDD exposure. 
Interestingly, TCDD significantly reduced Bax levels, but did not change Bcl2 levels in 
antral follicles compared to controls.  These data suggest that even though TCDD does 
not increase atresia, it still may regulate apoptosis pathways in antral follicles.  It is likely 
TCDD does so through the AHR.  When the AHR protein is down regulated by TCDD, 
this could lead to a deregulation of the proapoptotoc factor Bax, and an environment 
that favors survival over death in the follicle.  This could explain why, despite the severe 
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reduction in E2 production/secretion from TCDD exposed antral follicles, the follicles still 
grow and do not have increased atresia ratings when compared to vehicle controls 
(Karman et al., 2012).  This is similar in liver cells, where TCDD inhibits apoptosis, 
possibly through the AHR (Chopra et al., 2009; Chopra and Schrenk 2011).   
Another mechanism for TCDD ovotoxicity could be through altering enzymes 
responsible for producing and neutralizing reactive metabolites of E2.  TCDD exposed 
antral follicles have increased levels of Cyp1b1 and decreased levels of COMT (Karman 
et al., 2012).  Cyp1b1 is a phase I enzyme known for its ability to hydroxylate estrogens 
(Hayes et al., 1996; Parl et al., 2009).  Interestingly, it also metabolizes retinoids and 
arachidonic acid, it is inducible by cAMP, and its levels change in the ovary across the 
reproductive cycle; evidence that it plays critical roles in normal cellular function (Brake 
and Jefcoate 1995; Choudhary et al., 2004; Dasmahapatra et al., 2002; Murphy et al., 
2007).  Cyp1b1 hydroxylates E2 at carbon 4, producing catechol estrogen 4-OH-
estradiol.  4-OH-estradiol is highly reactive and can be further oxidized to semi-
quinones and quinones.  This process can generate free radicals such as superoxide 
anion causing oxidative stress, and quinones can react with DNA forming depurinating 
adducts (Paquette et al., 2005; Parl et al., 2009). 
The phase II enzyme COMT is a key enzyme in decreasing the effects of 4-OH-
estradiol by converting the catechol estrogen into the corresponding methoxy estradiol 
(Schendzielorz et al., 2011).  All of the tissues examined in this study have both a 
soluble and microsomal membrane form of COMT protein, with the soluble form 
predominating in the heart, lung and whole ovary (Fig 16 D).  Interestingly, antral 
follicles had equal amounts of both microsomal and soluble forms of COMT, unlike 
human luteinized granulosa cells that had predominantly the microsomal form (Vidal et 
al., 2005).  It is the microsomal membrane COMT that has significantly higher affinity for 
catechol substrates than the soluble COMT (Ulmanen and Lundström 1991).  In these 
studies, TCDD significantly reduced COMT protein levels in antral follicles compared to 
vehicle exposed antral follicles, with no concomitant change in Comt mRNA levels.  This 
differs from what was found in human luteinized granulosa cells exposed to TCDD 
(10nM) (Vidal et al., 2005).  Human luteinized granulosa cells had increased levels of 
Comt mRNA levels with no change in protein levels following TCDD exposure (Vidal et 
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al., 2005).  The differences could be related to the health status of the donor ovarian 
cells from infertility patients or due to the changes in granulosa cells after luteinization. 
Although levels of catechol estrogens have not been determined in TCDD 
exposed ovarian cells or antral follicles, it is likely that COMT rapidly methylates the 
catechol estrogens to limit local effects in the follicle.  This is evidenced by the 
production of 2-methoxyestradiol by pig granulosa cells and its presence in follicular 
fluid (Basini et al., 2012; Bianchi et al., 2007).  E2 levels in follicular fluid can reach 1500 
ng/mL during the mid to late follicular phase, making antral follicles sensitive targets for 
CYP1B1 induction and accumulation of catechol estrogens by TCDD (McNatty et al., 
2012).  Thus, because TCDD also causes reduced levels of the COMT enzyme in antral 
follicles, the damaging effects of reactive catechol estrogens could be exacerbated in 
the ovary following TCDD exposures.      
In conclusion, it is possible that catechol estrogens are elevated in antral follicles 
exposed to TCDD due to increased activity of P450 phase I enzymes such as Cyp1b1 
and decreased activity of phase II enzymes such as COMT.  This could cause 
generation of free radicals and DNA adducts in the ovary, leading to decreased oocyte 
quality and/or promotion of ovarian cancer.  Very little is known about how COMT is 
regulated in the ovary.  It is possible that the reduced E2 production/secretion by TCDD 
exposed antral follicles could preclude a reduction in the COMT enzyme because E2 
regulates the COMT enzyme in other tissues.  In addition to the effects of TCDD on E2 
metabolizing enzymes, it is possible that TCDD acts through the AHR to alter levels of 
apoptotic factors such as Bax in the antral follicle.  These two mechanistically distinct 
actions of TCDD on the ovary could collectively contribute to ovotoxcicity, endocrine 
disruption, and cancer promotion.  Due to the ubiquitous nature of dioxins such as 
TCDD, more studies are warranted to better characterize the actions of TCDD on cell 
death and cancer promotion in the ovary.      
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4.6 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 14 
 
Effect of TCDD exposure on the expression of Bcl2 and Bax transcript levels.  To 
determine whether TCDD exposure impairs expression of genes responsible for 
apoptosis, follicles were collected at the end of the culture period and subjected to 
measurements of transcripts for the anti-apoptotic factor Bcl2 (A) and the proapoptotic 
factor Bax (B).  Levels of Bcl2 and Bax were normalized to β-actin (Actb). Data are 
expressed as mean relative expression ratios ± SEM calculated from 3 - 4 separate 
culture experiments.  Column with asterisk indicates * p≤0.05.   
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Fig 15 
Effect of TCDD exposure on the expression of COMT mRNA in antral follicles.  To 
determine whether TCDD affects Comt mRNA levels, we compared the expression of 
Comt mRNA in antral follicles treated with vehicle or TCDD for 96 hours.  At the end of 
the culture period, follicles were assayed by real time quantitative PCR (qPCR) for the 
Comt transcript.  Levels of Comt were normalized to β-actin (Actb). Data are expressed 
as mean relative expression ratios ± SEM calculated from 3 - 4 separate culture 
experiments.   
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Fig 16 
Effect of TCDD exposure on the expression of COMT protein in antral follicles.  At 
the end of each of the cultures, 12-16 follicles from each treatment group were pooled 
and immediately snap frozen in liquid nitrogen and analyzed by western blot for COMT 
protein levels.    Antral follicles (250-350 μm) (F), ovary (O), heart (H), lung (L), and 
skeletal muscle (M) were removed from a PND 33 female mouse and analyzed as 
positive controls.  Densitometric units of the COMT protein bands were normalized to 
the densitometric units of the corresponding ACTB protein bands on each blot for 
quantification.  Data are expressed as mean relative expression ratios ± SEM calculated 
from four separate culture experiments (graph A represents the 48 hour cultures and 
graph C represents the 96 hour cultures).  B and D, are representative images of the 
protein bands from western blots for COMT with an image of the corresponding ACTB 
protein bands that were used as loading controls below.  mCOMT=membrane COMT, 
sCOMT=soluble COMT, V = vehicle control, T = 1nM TCDD, and X = blank lane.       
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Table 2 
Transcript 
NCBI reference 
sequence Forward primer sequence 5’- 3’ Reverse primer sequence 5’- 3’ 
Actb NM_007393.3 GGG CAC AGT GTG GGT GAC CTG GCA CCA CAC CTT CTA C 
Bcl2 NM_009741.3 ATG CCT TTG TGG AAC TAT ATG GC GGT ATG CAC CCA GAG TGA TGC 
Bax NM_007527.3 TGA AGA CAG GGG CCT TTT TG AAT TCG CCG GAG ACA CTC G 
Comt NM_001111062.1 TTC TTG ACC ACT GGA AAG ACC GCT TGA GCT GTA GTG TGT GCA CTC GAA 
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Chapter V:  Overall Conclusions and Future Directions 
 
I have shown that TCDD (1nM) reduces P production/secretion and dramatically 
reduces A4, T, and E2 production/secretion in follicles compared to vehicle controls. 
Further, I have shown that TCDD exposure decreases Cyp11a1 in antral follicles 
compared to vehicle controls and that pregnenolone co-treatment by-passes the 
disrupted steroid hormone production/secretion.  This is evidence of an inhibitory effect 
on the conversion of cholesterol to pregnenolone in the thecal cell layer due to TCDD 
exposure.  Although TCDD targets steroidogenesis in the thecal cells, evidence 
reported here and by others also supports the hypothesis that TCDD acts on the 
granulosa cells, evidenced by its major effects on the HSD17B1 and CYP19A1 
enzymes.  Furthermore, TCDD did not significantly affect E1 production/secretion, 
evidence of a more severe inhibition of the HSD17B1 compared to the CYP19A1 
enzyme.  This is the first report of the actions of TCDD on the HSD17B1 enzyme in the 
ovary.   
I have also shown that TCDD increases Cyp1b1 and decreases COMT in antral 
follicles.  This could lead to an elevation in catechol estrogens in antral follicles.  In turn, 
this could cause generation of free radicals and DNA adducts in the ovary, leading to 
decreased oocyte quality and/or promotion of ovarian cancer.  Very little is known about 
how COMT is regulated in the ovary.  It is possible that the reduced E2 
production/secretion by TCDD exposed antral follicles could preclude a reduction in the 
COMT enzyme because E2 regulates the COMT enzyme in other tissues.  TCDD 
exposure also leads to decreased levels of the proapoptotic factor Bax without altering 
atresia in antral follicles, an indication of a follicle that favors survival even under the 
potential insult of free radicals and dramatically reduced steroid hormone levels.   
These actions of TCDD on steroid hormone metabolism, TCDD and E2 
biotransformation, and cell death pathways are likely through an AHR pathway, as 
demonstrated by induction of the Cyp1b1 transcript, down regulation of the AHR protein 
and constitutive expression of the Ahr transcript in our culture system.  Transcriptional 
AHR activation by TCDD and other ligands may lead to proteasomal degradation and 
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chronic down regulation of the protein in the antral follicle.  This chronic down-regulation 
may dampen the toxic response pathway, rescuing the follicle from death, but also 
could cause deregulation of the endogenous actions of the AHR protein in the ovary.   
 
In summary, I have demonstrated that TCDD disrupts sex steroid hormone 
production in a non-monotonic dose response manner, without altering growth of mouse 
antral follicles.  When steroid hormone production/secretion by antral follicles is reduced 
due to TCDD (1nM) exposure, it involves a mechanism that inhibits the action of 
steroidogenic enzymes, alters the mitochondrial cell death pathways, and possibly 
induces DNA damage by reactive metabolites of TCDD and E2 without altering atresia 
in antral follicles.  These actions of TCDD in the antral follicle are primarily through an 
AHR mediated pathway.  Due to the ubiquitous nature of dioxins such as TCDD, more 
studies are warranted to better characterize the actions of TCDD on steroidogenesis, 
cell death and cancer promotion in the ovary.  Future studies should also be targeted at 
understanding the mechanisms of endogenous AHR function in the ovary and the 
consequences of exogenous ligand binding to this receptor. 
 
Future Directions 
The studies reported here leave some very compelling questions unanswered.  
Future studies should be directed at understanding the U-shaped dose response for 
steroid hormone production/secretion in TCDD exposed antral follicles.  One study 
examined TCDD exposed human luteinized granulosa cells via transmission electron 
microscope (TEM) techniques and found evidence of cellular damage not characteristic 
of apoptosis at very high doses of TCDD (3.1μM) (Heimler I et al., 1998).  Thus, it would 
be interesting to compare the cellular morphology of antral follicles via TEM after 
exposure to the various doses of TCDD (0.1-100nM).  It is possible that after exposure 
to the higher pharmacological doses of TCDD, cellular membranes in antral follicles are 
compromised, leading to leakage and increased hormone levels in the media when 
compared to the lower doses of TCDD.  This could also lead to studies examining non 
classical forms of cell death.  It would also be useful to compare levels of the 
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steroidogenic enzymes, phase I metabolizing enzymes such as CYP1B1, phase II 
metabolizing enzymes such as COMT, the apoptotic factors BCL2 and BAX, and the 
AHR in antral follicles after exposure to the various doses of TCDD.  These experiments 
would help to elucidate whether TCDD acts via more than one mechanism depending 
on the dose.  It would also be important to compare these factors at several time points 
to determine when TCDD begins to act and how long the effects persist in the antral 
follicle.  This could lead to studies investigating TCDD biotransformation in the antral 
follicle.  Although the ovary expresses enzymes known to metabolize dioxins such as 
TCDD, it has not been determined whether biotransformation of TCDD occurs in the 
ovary.  To study this, levels of TCDD and its metabolites could be measure by gas 
chromatography-mass spectrometry in antral follicles following various lengths of 
exposure.   
TCDD did not affect follicle growth as measured by average percent change in 
diameter on a perpendicular axis every 24 hours from the beginning of the culture.  To 
confirm that TCDD does not affect antral follicle growth in culture, it would be useful to 
co-culture antral follicles with the thymidine analogues 5-bromo-2'-deoxyuridine (BrdU) 
or 5-ethynyl-2´-deoxyuridine (EdU) and compare the percentage of proliferating cells in 
antral follicles exposed to vehicle or TCDD via light microscopy or fluorescent confocal 
microscopy techniques (Lin et al., 2009).  This technique would also allow us to 
distinguish between proliferation in the thecal cell layers and the granulosa cell layers.  
We could also compare levels of a marker for proliferation such as proliferating nuclear 
antigen (PCNA) in antral follicles exposed to vehicle or TCDD (Essers et al., 2005).  
This could be done by western blots to compare protein levels between vehicle and 
TCDD exposed follicles or by immunohistochemistry (IHC) to compare the percentage 
of cells preparing to divide between vehicle and TCDD exposed follicles (Assy et al., 
1998). 
Levels of the phase I metabolizing enzyme Cyp1b1 are increased and levels of 
the phase II metabolizing enzyme are reduced in antral follicles exposed to TCDD 
compared to vehicle controls.  Thus, it is possible that TCDD increases the production 
of reactive estrogen metabolites and that exposed follicles have a reduced ability to 
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neutralize them.  To test this hypothesis, levels of catechol estrogens such as 4-
hydroxyestradiol (4-OHE) could be compared between vehicle and TCDD exposed 
antral follicles using solid-phase extraction (SPE) and matrix solid-phase dispersion with 
(MSPD) gas chromatography-mass spectrometry (GC-MS), as was demonstrated with 
pig follicles (Bianchi et al., 2007).  Increased levels of these metabolites could be an 
indication of DNA damage.  To test for DNA damage, levels of DNA adduct formation 
could be compared between vehicle and TCDD exposed antral follicles (Murdoch et al., 
2005).  It has been suggested that increased levels of hydroxyestrogens are also 
associated with inhibited vessel growth in antral follicles (Basini et al., 2008).  Vessel 
growth is important for follicle growth and ovulation.  Ovulation is severely reduced in 
animals exposed to TCDD.  Thus, this could be an endpoint to investigate in animal 
studies.  Interestingly, chicken embryos exposed to TCDD had lower levels of vascular 
endothelial growth factor (VEGFA) in their hearts compared to controls (Ivnitski-Steele 
et al., 2004).  Thus, levels of endothelial growth factors such as VEGFA could be 
compared in the ovaries between vehicle and TCDD exposed animals to determine if 
TCDD affects vessel growth in the ovary.   
Finally, the AHR and retinoic acid (RA) pathways interact and both are important 
for steroidogenesis in the follicle (Baba et al., 2005; Murphy et al., 2007; Yanase et al., 
2001; Barnett et al., 2007; Kushida and Tamura 2009; Laville et al., 2006; Pawlowska et 
al., 2008).  Specifically, TCDD acting through the AHR alters RA biosynthesis, 
metabolism, and storage, as well as alters gene transcription of a variety of genes 
critical for the physiological effects mediated by the RA pathway (Hoegberg et al., 2005; 
Murphy et al., 2007).  RA is ligand for the retinoic acid receptors such as the retinoid X 
receptor (RXR).  In human granulosa cells, the ligand bound RXR and its heterodimer 
partner peroxisome proliferator-activated receptor (PPARgamma) have been implicated 
in modulating E2 production by controlling aromatase levels and activity in human 
granulosa cells (Fan et al., 2005).  If the AHR pathway is capable of interfering with RA 
signaling in the follicle, one mechanism could be through AHR mediated induction of 
P450 enzymes, such as Cyp1b1, which besides hydroxylating E2 is also capable of 
hydroxylating RA, resulting in an inhibition of RXR actions on CYP19A1 and ultimately 
exacerbating the decreased E2 production in TCDD exposed follicles.  Thus, it would be 
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interesting to compare RA metabolite levels in the media from antral follicles exposed to 
TCDD or vehicle alone to determine whether TCDD leads to hydroxylation of RA.  It 
would also be interesting to culture follicles from RXR deficient mice to see if the effects 
of TCDD on CYP19A1 require RXR signal transduction (Hoegberg P et al., 2005).  To 
further support this hypothesis, follicles from wild type mice could be co-cultured with 
TCDD and all trans retinoic acid (atRA), TCDD alone, or vehicle alone.  Levels and 
activity of CYP19A1 could be measured to determine whether atRA rescues the 
transcription and activity of this enzyme in TCDD exposed antral follicles.          
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Chapter VI:  Supplement: The AHR regulates germ cell and somatic cell proliferation in 
the ovary during embryonic life, controls germ cell nest breakdown, and regulates Kif11 
and Xist transcripts during neonatal life in the developing ovary 
6.1 Abstract 
 
Although the establishment and maintenance of the primordial follicle pool and 
meiotically competent oocytes are absolutely essential for female reproductive function, 
very little is understood about the factors that control these processes.  Published data 
suggest that the aryl hydrocarbon receptor (AHR) may be a regulator of embryonic 
germ cell dynamics and primordial follicle formation.  Specifically, germ cells from AHR -
/-  female embryonic mice seem more resistant to cell death, and AHR -/- mice establish 
their primordial follicle pool earlier than WT mice.  Thus, we tested the hypothesis that 
the AHR regulates germ cell nest breakdown.  First, to confirm the presence of the AHR 
and compare its levels during the period of germ cell development and primordial follicle 
assembly, ovaries were collected on embryonic day (ED) 13.5, ED 15.5, postnatal day 
(PND) 2, and PND 8 and assayed by western blot for the AHR protein.  The AHR 
protein was present and its levels remained relatively constant throughout development 
in the ovary.  Next, we tested the hypothesis that the AHR is involved in controlling 
germ cell nest breakdown, a prerequisite for primordial follicle assembly.  To do so, 
ovaries were collected from AHR -/- and WT mice on PNDs 2 and 8 and histologically 
evaluated for number and size of germ cell nests.  The results from the histological 
evaluation suggest that there was more germ cell nest breakdown between PND 2 and 
8 in the AHR -/- ovaries when compared to the WT ovaries as evidenced by a significant 
decrease in the number of nests between PND 2 and 8.  Thus, we hypothesized that 
the AHR regulates the expression level of genes known to regulate primordial follicle 
pool formation.  To do so, ovaries were collected from AHR -/- and WT mice on PND 2 
and PND 8, and analyzed by Affymetrix GeneChip® 430 2.0 Mouse Genome arrays to 
compare the expression of more than 20,000 genes.  Interestingly, a gene necessary 
for maintaining spindle structure and proper movement of chromosomes during the cell 
cycle, kinesin family member 11 (Kif11), was significantly increased by 2 fold in the AHR 
-/- ovaries compared to the WT ovaries.  This result was confirmed by quantitative RT-
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PCR (WT = 1.67±0.15, AHR -/- = 3.32±0.55 relative expression level, n=4, p≤0.05). 
Interestingly, a gene essential for initiation of X chromosome inactivation, inactive X 
specific transcripts (Xist), was decreased by 2 fold in the AHR -/- ovary compared to the 
WT ovary.  This finding was also confirmed by quantitative RT-PCR (WT = 1.10±0.12, 
AHR -/- = 0.68±0.04 relative expression level, n=5, p≤0.05).  It has been proposed that 
the genetic competence and quality of the primordial follicle pool is determined during 
embryonic development in the ovary.  Both the somatic cells and the developing germ 
cells provide factors that are important for promoting proliferation and initiating and 
completing meiosis in the embryonic ovary.  Thus, we also tested the hypothesis that 
the AHR regulates proliferation in the ED 11.5 ovary, a developmental stage just after 
initial primordial germ cell colonization.  To do so, pregnant AHR heterozygous (-/+) 
dams were injected on the morning of ED 11.5 with the thymidine analog, 5-ethynyl-2’-
deoxyuridine (EdU).  Six hours later, the embryonic gonads were isolated, AHR and XY 
genotypes confirmed, and ovaries were analyzed for proliferation and germ cell number 
using fluorescent confocal microscopy techniques.  The results indicate that there was 
more cell proliferation in the AHR -/- ED 11.5 ovaries compared to the WT ED 11.5 
ovaries as measured by a significantly higher volume ratio of nuclei in S phase of the 
cell cycle to total nuclei volume.  Additionally, there was a significantly higher ratio of 
germ cells in S phase of the cell cycle to total germ cell number in AHR -/- ED 11.5 
ovaries compared to WT ED 11.5 ovaries.  Concurrently, there was no significant 
difference in the total number of germ cells per ovary between AHR -/- and WT ED 11.5 
ovaries.  These data suggest that the AHR plays important physiological functions in the 
ovary during critical stages of embryonic and neonatal development in the mouse.      
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6.2 Introduction 
The formation of an adequate and healthy primordial follicle pool in the 
developing ovary is a process that predicts female fertility and the age of reproductive 
senescence (Hartshorne et al., 2009; Hirshfield 1991;Pepling and Spradling 2001; 
Tingen et al., 2009).  This is due to the established opinion that female mammals are 
endowed at birth with a finite number of germ cells in their ovaries (Greenfeld and Flaws 
2004; Telfer et al., 2005).  The size and reproductive capacity of the primordial follicle 
pool involves a dynamic interplay between programmed cell death and proliferation of 
somatic and germ cells both embryonically and neonatally (Krysko et al., 2008).  A 
complete failure to form or a severe reduction in size of the primordial follicle pool in the 
ovary can be the result of excessive cell death or insufficient proliferation of somatic and 
germ cells (Balla et al., 2006; De Felici et al., 2005).  Factors that promote cell 
proliferation, survival, and death in the germ cells and somatic cells have been shown to 
influence the size of the primordial follicle pool (Acevedo and Smith 2005).  Additionally, 
the accumulation of RNA transcripts and proteins in developing oocytes can predict 
their reproductive competence and genetic quality because they provide growth and 
survival factors and prime the ooctyes for meiotic events during oocyte maturation, 
follicle growth, ovulation, and fertilization (Acevedo and Smith 2005; Baltus et al., 2006; 
Dean 2002).  Meiotic defects in the developing germline can lead to chromosome 
structure abnormalities, which can cause germ cell death embryonically or postnatally, 
and affect egg quality (Baudat et al., 2000; Hunt and Hassold 2008). 
Problems in the normal process of primordial follicle pool formation and 
maintenance have numerous clinical applications.  Woman who fail to form an adequate 
and healthy primordial follicle pool or fail to maintain that pool can experience early 
menopause, also known as early ovarian failure (Hirshfield 1991).  Early ovarian failure 
is associated with an increased risk of cardiovascular disease, osteoporosis, and 
premature death (Armamento-Villareal et al., 1992; Bagur and Mautalen 1992; Cooper 
and Sandler 1998; Everson et al., 1995; Hu et al., 1999; Sowers and La Pietra 1995; 
Wrensch et al., 1990).  Also, women with defective oocytes can experience problems 
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with ovulation, fertilization and recurrent embryo loss (Hunt and Hassold 2008; Matzuk 
and Lamb 2008).  
Gestation in the mouse occurs over an approximately 20-day period, during 
which germ cells migrate and colonize the genital ridge by embryonic day (ED) 10.5 
(Hirshfield 1991; Pepling 2006; Tingen et al., 2009).  This event marks the onset of 
ovarian development.  The colonizing germ cells rapidly proliferate and remain 
connected by cellular bridges due to incomplete cytokinesis, forming into clusters 
(Hirshfield 1991; Pepling and Spradling 1998).  Somatic cells of the developing ovary 
also proliferate extensively and some of the cells envelop the germ cell clusters in a 
single layer with an outer basement membrane, forming nests (Guigon and Magre 
2006; Warner et al., 2007).  The germ cells begin to arrest mitosis and enter meiosis 
around ED 13.5 to become oocytes (Pepling 2006).  The oocytes progress though the 
early stages of meiotic prophase I, until they become arrested in the diplotene stage 
around ED 17.5.  Concurrently, many of the germ cells die via programmed cell death 
(PCD), in a process termed oocyte attrition (Gondos 1978). The process of attrition 
occurs during each phase of oogenesis in both mitotic and postmitotic germ cells 
(Ghafari et al., 2007; Gondos 1978).   However, most of the germ cells are lost 
postmitotically between ED 13.5 and postnatal day (PND) 5 (Ghafari et al., 2007; 
Hirshfield 1991; McClellan et al., 2003).  This massive wave of germ cell death from the 
time of birth until PND 5 is thought to aid in germ cell nest breakdown and primordial 
follicle assembly.  During this period, there is an approximately 70% reduction in the 
number of oocytes (Pepling and Spradling 2001).  The individual surviving oocytes that 
break away from the nests are then assembled into primordial follicles consisting of a 
single oocyte, a mono-layer of pre-granulosa cells, and a basement membrane 
encompassing the oocyte (see diagram 1).  The process of primordial follicle assembly 
is generally complete by PND8 in the mouse (Hirshfield 1991).  The primordial follicles 
formed during this period represent a finite pool available to the female for the entire 
reproductive lifespan (Hirshfield 1991;Mandl and Zuckerman 1951).  Once the 
primordial follicles are formed, some begin to grow within a few days, but most of them 
remain quiescent and do not start to grow until months, or even years later (Matzuk et 
al., 2002).  
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Although the establishment and maintenance of the primordial follicle pool and 
meiotically competent oocytes are absolutely essential for female reproductive function, 
very little is understood about the factors that control these processes.  Currently, it is 
unclear what determines the fate of mammalian primordial germ cells and what signals 
the development of the embryonic and neonatal ovarian cell types.  Published data 
suggest that the aryl hydrocarbon receptor (AHR) may be a regulator of embryonic 
germ cell dynamics and primordial follicle formation.  Specifically, germ cells from AHR -
/-  female embryonic mice seem more resistant to cell death, and AHR -/- mice establish 
their primordial follicle pool earlier than WT mice (Benedict et al., 2000; Robles et al., 
2000).  Also, more recently it was demonstrated that polcyclic aromatic hydrocarbon 
(PAH) exposure suppresses meiosis initiation and completion in chicken primordial 
germ cells and that this is primarily through the AHR (Ge et al., 2012).  Most of the germ 
cells that fail to initiate or complete meiosis die via apoptosis (Hartshorne et al., 2009).  
Interestingly, it has also been shown that besides regulating meiosis, the AHR may 
regulate germ cell death in the embryonic and neonatal ovary through control of the 
proapoptotic factor BCL2-associated X protein (BAX) (Kee et al., 2010; Matikainen et 
al., 2001; Matikainen et al., 2002).   
Notably, the AHR is expressed in both the germ cells and somatic cells of the 
ovary and both cell types produce factors that drive proliferation, survival, meiosis, and 
death (Baldridge and Hutz 2007; Liu et al., 2010; Matzuk et al., 2002; Ratts et al., 1995; 
Sakurada et al., 2011).  Also, adult female AHR -/- mice have reduced fertility partly due 
to lower numbers of preantral and antral follicles able to reach ovulation compared to 
WT mice (Abbott et al., 1999; Baba et al., 2005; Barnett et al., 2007).  The physiological 
function of the AHR in the fetal and neonatal ovary could involve mediating proliferation, 
death, and meiosis.  When the AHR is lacking or activated by ligands, this could result 
in defective oocytes and/ or follicles able to reach ovulation during adult life.  Thus, 
these studies were aimed at investigating involvement of the AHR in regulating 
proliferation and germ cell number in the embryonic ovary and germ cell nest 
breakdown in the neonatal ovary. We also tested the hypothesis that the AHR regulates 
factors involved in the process of proliferation, death, and meiosis in the neonatal ovary.   
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6.3 Materials and Methods 
 
Animals 
Founding male and female AHR heterozygote (+/-) breeders on a C57BL/6J 
background, originating from Schmidt et al. (1996), were bred at the University of 
Illinois, Urbana-Champaign. Genotypes of pups resulting from AHR +/− male/female 
crosses were determined by PCR as previously described (Benedict et al., 2000).  Wild 
type (WT +/+) siblings were used as controls in these experiments.  All mice were 
housed under strict 12L:12D lighting and temperature was maintained at 22±1ºC.  Food 
and water were provided ad libitum.  Animals were maintained in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals, and all 
protocols were approved by the University of Illinois Animal Care and Use Committee.    
 
 
Analysis of AHR protein levels 
The presence and/ or levels of the AHR were compared across development of 
the mouse ovary.  To do so, female and male C57BL/6J WT adult mice were paired in 
individual cages in the early evening.  Embryonic day 0.5 was determined by the 
presence of vaginal sperm plugs on the following morning.  On embryonic days 13.5 
and 15.5 at the same time in the afternoon, pregnant dams were euthanized and 
embryos were removed from the uterine horns.  Female gonads were removed from 
each embryo, dissected free of mesonephros, and snap frozen in liquid nitrogen.  Tail 
and limb pieces were also collected from each embryo and snap frozen for DNA 
isolation, AHR genotyping, and XY genotyping to confirm sex (Gubbay J et al., 1992).  
Also, ovaries were removed from female pups on PND 2 and PND 8 and snap frozen in 
liquid nitrogen (PND 0 = day of birth).  DNA from tail pieces was analyzed for AHR 
genotyping.  AHR -/- embryonic and neonatal ovaries were then lysed and 
homogenized in T-Per (50uL for embryonic and 300uL for neonatal ovaries) (Thermo 
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Fisher Scientific, Rockford, IL) containing protease inhibitors (Roche Diagnostics, 
Mannheim, Germany).  For a positive control, the liver was also removed and 
immediately snap frozen and stored at -80ºC until analysis by western blot.  Tissues 
were lysed and homogenized in T-Per containing protease inhibitors according to 
manufacturer’s instructions. After tissue lysis, homogenization, and centrifugation, the 
protein concentration in the supernatant was determined by using a bicinchoninic acid 
(BCA) assay kit (Thermo Fisher Scientific, Rockford, IL). Electrophoresis and 
immunoblotting were performed using XCell SureLock Mini-Cell Blot Module Kit and 
recommended reagents as per manufacturer's protocol (Invitrogen, Carlsbad, CA). The 
protein lysate (2 μg) was loaded on precast 4–12% bis-tris sodium dodecyl sulfate-
polyacrylamide gels (SDS-PAGE; Invitrogen, Carlsbad, CA), followed by transfer of the 
proteins to 0.45μm InvitralonTM polyvinylidene difluoride membranes (Invitrogen, 
Carlsbad, CA) at 4 °C. The blot was blocked with 5% non-fat milk for one hour at room 
temperature and then incubated overnight at 4 °C with the AHR primary antibody (AHR 
BML-SA210, 1:5000 (Enzo Life Sciences, Plymoth Meeting, PA).  After three washes, 
the membrane was then incubated for one hour at room temperature with the 
appropriate horseradish peroxidase (HRP) conjugated secondary antibody (goat anti-
Rabbit HRP ab6721, 1:5000 (Abcam Inc., Cambridge, MA).  To ensure uniform loading 
of the proteins, the blots were then incubated with the anti-beta actin antibody (ACTB) 
ab8227, 1:5000 (Abcam Inc., Cambridge, MA) followed by incubation with the 
appropriate horseradish peroxidase (HRP) conjugated secondary antibody.  The 
immune complexes on the blots were visualized using an enhanced chemiluminescence 
detection kit (Cell Signaling Technologies, Danvers, MA) and captured on X-ray film. 
Scanning densitometry using the Image J software downloaded from the NIH website 
(http://rsb.info.nih.gov/ij/) was used to compare the protein levels. Specifically, 
densitometric units of the AHR protein bands were normalized to the densitometric units 
of the corresponding ACTB protein bands on each blot for quantification. 
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Histological evaluation of germ cell nest breakdown 
To investigate whether the AHR is involved in controlling germ cell nest 
beakdown, ovaries were collected from AHR -/- and WT mice on PNDs 2 and 8 (PND 0 
= day of birth).  These times were selected because PND 2 is when the process of 
primordial follicle pool formation is still occurring and oocye attrition is at its peak.  PND 
8 is when these processes are almost complete in the mouse ovary.  The ovaries were 
fixed in Detrick’s solution, embedded in paraffin, serially sectioned, stained with 
Weigert’s hematoxylin acid methyl blue as previously described (Benedict et al., 2000). 
Every tenth serial section was subjected to histological evaluation for the number of 
germ cell nests and the number of germ cells contained within each nest.  
 
 
Analysis of transcript levels 
Ovaries from PND 2 and 8 AHR -/- and WT mice were isolated and immediately 
snap frozen in liquid nitrogen and stored at -80ºC until quantitative real time PCR 
(qPCR) analysis.  Total RNA was extracted using the RNeasy Mini Kit according to the 
manufacturer’s instructions (Qiagen, Valencia, CA).  Concentration, purity, and quality 
of the RNA were determined using the NanoDrop ND-1000 UV-Vis spectrophotometer 
at 260 nm and 280 nm (Nanodrop Technologies, Wilmington, DE).  An equal amount of 
RNA from 6 animals (12 ovaries) in each of the four groups was pooled, amplified, 
labeled, and subjected to Affymetrix GeneChip® 430 2.0 Mouse Genome arrays to 
compare the expression of more than 20,000 genes.  The differentially expressed 
Affymetrix tags that showed an increased or decreased signal of two fold or higher 
when compared to the control (WT) and passed the change p-value (change p-values of 
0.0025 or less = increase and change p-values of 0.9975 = decrease over all probe sets 
used on the array) were mapped to known genes and those genes were compiled into 
two lists (PND2 AHR -/- versus WT and PND8 AHR -/- versus WT).  These lists 
revealed a differential expression of 147 genes in the AHR -/- versus WT ovaries (123 
up-regulated and 24 down-regulated genes in the AHR  -/- ovaries versus WT ovaries) 
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on PND 2 and differential expression of 602 genes in the AHR-/- versus WT ovaries 
(387 up-regulated and 215 down-regulated genes in the AHR -/- versus WT ovaries) on 
PND 8.  We then used these lists to perform pathway analysis and categorize genes by 
biological process based on their gene ontology utilizing the bioinformatics program 
called DAVID (database for annotation, visualization, and integrated discovery) (See 
table 3) (Huang da et al., 2009). 
To validate the array results, total RNA (500ng) from the same PND 2 and 8 
ovaries used in the array experiment was reverse transcribed using an iScript cDNA 
synthesis kit according to manufacturer’s instructions (Bio-Rad, Hercules, CA).  
Negative controls included omission of reverse transcriptase and omission of template.  
Each of the final cDNA samples were then diluted 1:4 for real time qPCR analysis.  All 
qPCR reactions were performed in triplicate using the CFX96 Real-time System C1000 
Thermal Cycler (Bio-Rad).  Each qPCR reaction contained 5μL of 2X SsoFastTM 
Evagreen® supermix, 0.6μL of gene specific primers, 2.4μL of nuclease free water, and 
2μL of diluted cDNA template.  The final concentration for each gene specific primer in 
the qPCR reactions was 0.3pmoles/ μL.  Primers were designed to be specific for a 
sequence of the transcript found within the specific probe sets from the array.  A 
BLASTN search was performed in GenBank to ensure that all primers were unique to 
the gene of interest. To avoid amplification from genomic DNA contamination, all primer 
sets spanned a large exon-intron-exon junction.  Primer sequences are shown in table 
4.  Initial denaturation of the cDNA and enzyme activation occurred at 95ºC for 1 min, 
followed by 40 cycles of (10 seconds at 95ºC, 10 seconds at 60ºC, and a fluorescent 
absorbance reading), and one final annealing/elongation step for 5 minutes at 72ºC.  A 
heat dissociation curve (from 65ºC-95ºC with a fluorescent absorbance reading after 
each 0.5ºC increment) was performed at the end of every run to assure specificity of 
each primer pair for the chosen transcript of interest.  
 For relative quantification of transcript levels, standard curves were generated 
using a six step serial dilution of cDNA generated from pooled RNA samples for each 
primer set being used.  These standard curves were used to calculate the amplification 
efficiencies for each primer pair.  Relative transcript amount was then calculated by a 
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mathematical model developed by Pfaffl (Pfaffl 2001).  Briefly, the method involves 
calculating the relative expression ratio of the target gene based on the amplification 
efficiency of each amplicon and the ΔCt of the treated samples versus the vehicle 
control.  These ratios were then compared to the expression of the reference gene 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh).  Gapdh was verified as a good 
internal control because its levels were unchanged with genotype (data not shown).  
The data were reported as mean transcript expression ratios relative to Gapdh (n= 5-6 
ovaries, p≤0.05).   
 
 
  
5-ethynyl-2’-deoxyuridine (EdU) incorporation and whole mount immunohistochemistry 
of female gonads 
    Adult female and male AHR +/- mice were paired in individual cages in the early 
evening.  Embryonic day 0.5 was determined by the presence of vaginal sperm plugs 
on the following morning.  Pregnant dams were injected intraparitoneally (i.p.) with 
50mg/kg of EdU in sterile PBS on the morning of ED 11.5 (Molecular Probes, Eugene, 
OR).  The volume and molarity of the injected solution was approximately 200uL and 
30mM respectively.  The dams were euthanized 6 hours later with CO2 followed by 
cerebral dislocation.  Embryos were dissected from the uteri and embryonic sacs in cold 
1X PBS.  Gonadal ridges were dissected under a dissecting light microscope from each 
embryo in separate clean dishes containing cold 1X PBS.  Limbs and tail pieces from 
each embryo were snap frozen at -80 ºC for sexing and genotyping.  The gonadal 
ridges were then placed in freshly prepared 4% paraformaldehyde (EM grade) and fixed 
overnight.  Then, they were rinsed 3 times in cold 1X PBS and stored at 4 ºC until the 
sex and genotypes for each embryo were determined.  DNA from the tail and limb 
pieces was isolated and analyzed by PCR for XY genotyping as previously described 
(Gubbay et al., 1992).  DNA from female embryos was then analyzed for AHR 
genotypes as described above.  Female AHR -/- and WT gonadal ridges were then 
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permeabilized in 0.5% Triton X-100/ 1X PBS overnight with oscillation at 4 ºC.  They 
were then washed with 3% BSA/ 1XPBS 2 times for five minutes each.  Gonadal ridges 
were then incubated protected from light for 30 min in 250uL of Click-iT EdU Alexa 
Fluor® 647 reaction cocktail (C10340) as recommended by the manufacturer (Molecular 
Probes, Eugene, OR).  The reaction cocktail was then removed and female gonadal 
ridges were washed with 3% BSA/ 1XPBS and blocked with 5% normal heat inactivated 
goat serum (NGS) (Vector Labs), 10% Image-iT®FX signal enhancer (ITFX) (Invitrogen) 
in 1X PBS over night at 4 ºC protected from light.  Gonads were then incubated over 
night at 4 ºC with an anti-GCNA1 (germ cell nuclear antigen 1) rat IgM antibody 
generously provided by Dr. Enders (University of Kansas) diluted in wash buffer 1:50 
(0.1% TX-100, 5% NGS, 10% ITFX, 1XPBS).  They were then washed three times in 
wash buffer followed by an overnight incubation with an anti-rat IgM Alexa Fluor® 488 
antibody at 4 ºC (Invitrogen A21212).  After the overnight incubation, the gonadal ridges 
were then washed 3X in wash buffer and then once more with 1XPBS followed by 
Hoescht at 67μg/mL (Invitrogen 33342) in 1XPBS for counter staining of the nuclei.  
Gonads were washed 2 more times in 1X PBS before mounting on and under #1 cover 
glasses (Fisherfinest Premium Cover glass) using one secure seal image spacer 
(Sigma S7935) and ProLong® Gold antifade reagent (Invitrogen P36930).  Coverslips 
were then allowed to cure at room temperature protected from light for 24 hours before 
sealing with clear nail polish and then maintained at 4ºC until imaging by confocal 
microscopy.  
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Confocal laser scanning microscopy, deconvolution, and three-dimensional rendering  
Samples were imaged using a 40× EC Plan-Neofluar DIC 1.3 M27 oil immersion 
objective in a Zeiss LSM 700 laser scanning confocal microscope (Carl Zeiss). The 
images were obtained using a 405 ultraviolet diode laser with increasing power, from 
2.2 - 6.5% for Hoescht labeling of DNA (410–450 nm emission), 488 Ar laser with 
increasing power, from 0.3 – 0.7% for GCNA labeling of germ cells (500–550 nm 
emission), and a 639 nm HeNe mixed gas laser with increasing power, from 0.4-1.1% 
for EdU labeling of proliferating cells (650–700 nm emission). The individual channels 
were obtained in a sequential scan mode so there was no excitation signal bleed 
through. Gain, and offset were kept constant across the samples and scanned in a high 
resolution format of 1024 × 1024 pixels with 2/4 frame averaging. Multiple two-
dimensional (2D) image stacks (512 × 512 pixels) were taken along the Z axis from the 
surface of the ovary to 35μm deep. Raw data of the Z stacks were deconvoluted (Fig 20 
B and E) using a blind deconvolution algorithm under 10 constrained iterations and low 
noise setting (Autoquant version X 2.2; Media Cybernetics, mediacy.com).  Single 
optical planes of all three channels merged (GCNA1, EdU, and Hoescht) were 
displayed for each z stack image and examined for germ cell number (Fig 20 A and D); 
3D volume isosurfaces were rendered for each channel using the Surpass module in 
the Imaris suite software for quantification of EdU and Hoescht positive staining (Fig 20 
C and F) (Bitplane). Proliferation was represented as a ratio of the volume of EdU 
positive stained nuclei over the Hoescht stained total nuclei volume calculated from 
isosurface volumes (n=3 ovaries; two fractions from each ovary were imaged and 
analyzed for each group (AHR -/- or WT)).  Figure 20 A-C is representative of an area 
imaged from a WT ovary and Figure 20 D-F is representative of an area imaged from a 
KO ovary.    The volume of the female gonad was estimated by multiplying the length by 
the width by the height.  The volume analyzed in the z stack images represents 
approximately 1/10th of each ovary.  Germ cells in the ED 11.5 ovary were evenly 
dispersed, so the germ cell counts were multiplied by 10 to estimate the total number of 
germ cells per ovary, as previously demonstrated (Pepling ME and Spradling AC2001).    
 
125 
 
Statistical Analysis 
Independent samples t-tests were used to analyze the data.  If the data did not 
pass the assumption of homogeneity of variance, the non-parametric Mann-Whitney U 
test was employed.  Statistical significance was assigned at p≤0.05 for all comparisons.  
All data were analyzed using SPSS 11.0 statistical software (SPSS Inc., Chicago, IL). 
 
 
6.4 Results 
 
 
Levels of the AHR protein in the ovary during embryonic and neonatal development 
To determine if the AHR is present and/or changes expression levels during 
ovarian development, ovaries at various stages of development were isolated and 
assayed by western blot for AHR protein levels.  Embryonic day 13.5 was chosen 
because female germ cells are initiating meiosis, embryonic day 15.5 was chosen 
because this is when female germ cells are arresting meiosis, postnatal day (PND) 2 
was chosen because this is when germ cell attrition peaks and primordial follicles are 
assembling, and PND 8 was chosen because this is when the primordial follicle reserve 
is almost established in the developing mouse ovary (Pepling and Spradling 2001).  The 
AHR protein was present and its levels remained relatively constant throughout 
development in the ovary (Fig 17).   
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Effect of AHR deletion on germ cell nest dynamics during development in the neonatal 
mouse ovary 
The AHR is involved in the timing of primordial follicle pool formation (Benedict et 
al., 2000).   A prerequisite for primordial follicle assembly is germ cell nest breakdown.  
Thus, we tested the hypothesis that the AHR regulates germ cell nest breakdown.  To 
test this hypothesis, we collected ovaries from AHR -/- and WT mice on PNDs 2 and 8.  
These times were selected because PND 2 is when the process of primordial follicle 
assembly is still occurring and PND 8 is when the process is almost complete in the 
mouse.  The histological evaluation revealed that the number of germ cell nests in WT 
ovaries between PND 2 and 8 did not change (see Fig 18 A).  Concurrently, the size of 
the germ cell nests decreased between PND2 and PND8 (Fig 18 B), indicating that the 
nests are breaking apart and primordial follicles are being assembled in the WT 
neonatal ovaries.  In contrast to the WT ovaries, the number of germ cell nests 
decreased significantly between PND 2 and 8 in the AHR -/- neonatal ovaries (Fig 18 
C).  However, concurrently, there was a similar decrease in the size of the nests 
between PND 2 and 8 in the AHR -/- ovaries compared to the WT ovaries.  Notably, the 
AHR -/- ovaries contained significantly more germ cell nests than the WT ovaries at 
PND 2 (on average there were 33±5.8 nests in the AHR -/- ovaries and only 10±2.3 
nests in the WT ovaries), but contained similar numbers by PND 8.   
 
 
Effect of AHR deletion on gene expression during primordial follicle assembly in the 
neonatal ovary  
Since the data described above implicate involvement of the AHR in the process 
of primordial follicle pool formation, we decided to investigate this in more detail.  
Specifically, we conducted some exploratory experiments to test the hypothesis that the 
AHR regulates the expression level of genes known to regulate primordial follicle pool 
formation, including those genes known to regulate cell proliferation, cell death, and 
meiosis.  To test this hypothesis, we collected ovaries from WT and AHR -/- ovaries on 
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PNDs 2 and 8 and extracted their mRNA.  We selected PND 2 because this is the time 
when primordial follicles are still being assembled.  PND 8 was selected because this is 
the time when formation of the primordial follicle pool is almost complete in the mouse.  
An equal amount of RNA from 6 animals (12 ovaries) in each of the four groups was 
pooled, amplified, labeled, and subjected to Affymetrix GeneChip® 430 2.0 Mouse 
Genome arrays to compare the expression of more than 20,000 genes.  The 
differentially expressed Affymetrix tags that showed an increased or decreased signal of 
two fold or higher when compared to the control (WT) and passed the change p-value 
(change p-values of 0.0025 or less = increase and change p-values of 0.9975 or more = 
decrease over all probe sets used on the array) were mapped to known genes and 
those genes were compiled into two lists (PND2 AHR -/- versus WT and PND8 AHR -/-
versus WT).  These lists revealed a differential expression of 147 genes in the AHR -/-
versus WT ovaries (123 up-regulated and 24 down-regulated genes in the AHR -/- 
ovaries versus WT ovaries) on PND 2 and differential expression of 602 genes in the 
AHR -/- versus WT ovaries (387 up-regulated and 215 down-regulated genes in the 
AHR -/- versus WT ovaries) on PND 8.  Only probes with signal intensity of 50 or above 
were considered for analysis (omitting Nr2c2, Hspa9 and Csf1). 
We then used these lists to perform pathway analysis and categorize genes by 
biological process based on their gene ontology utilizing the bioinformatics program 
DAVID (database for annotation, visualization, and integrated discovery) (Huang da W 
et al., 2009).  Notably, some of the genes listed in the meiosis category were not 
grouped by DAVID, but predicted by probability using a naïve Bayesian model (Zheng P 
et al., 2009).  Interestingly, many of the genes fit into categories related to cell 
proliferation, cell death, and meiosis (please see Table 3).  Real time qPCR was used to 
confirm the changes in mRNA levels identified from the arrays.  Only two of the genes 
(Kif11 and Xist) were validated using qPCR.  Specifically, kinesin family member 11 
(Kif11) transcript levels in AHR -/- PND 2 ovaries were 2 fold higher than in WT PND 2 
ovaries (WT = 1.67±0.15, AHR -/- = 3.32±0.55, relative expression level, n=4, p≤0.05) 
(Fig 19 A).  Inactive X specific transcripts (Xist) mRNA levels were 2 fold lower than in 
WT PND 2 ovaries (WT = 1.10±0.12, AHR -/- = 0.68±0.04, relative expression level, 
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n=5, p≤0.05) (Fig 19 A).  The levels of the other 9 genes did not pass validation, and 
their levels did not change between the AHR -/- and WT ovaries (Fig 19 A and B). 
 
 
Effect of AHR deletion on cell proliferation in the embryonic ovary 
Little is known about which factors are important for regulating establishment of 
the primordial follicle pool in the ovary.  It has been proposed that a dependence on 
growth factors is a way of matching the number of oocytes to the number of somatic 
cells for primordial follicle assembly (Krysko et al., 2008).  In this case, a defined ratio of 
ovarian cell types and close communication between them would be required for normal 
development.   Thus, because AHR-/- postnatal mice establish their primordial follicle 
reserve earlier when compared to WT mice, we tested the hypothesis that the AHR is 
an important factor that regulates the amount of proliferation in the ovary embryonically 
(Benedict et al., 2000; Matikainen et al., 2001; Matikainen et al., 2002; Robles et al., 
2000).  To test this hypothesis, we injected pregnant dams from heterozygote matings 
on embryonic day 11.5 with EdU and compared the volume ratio of cells in S phase of 
the cell cycle to total cell volume between WT and AHR-/- embryonic 11.5 ovaries using 
2 dimensional fluorescent microscopy imaging and quantification techniques.  ED 11.5 
was chosen because this is one day after initial primordial germ cell colonization and 
both germ cells and somatic cells are rapidly dividing in the ovary.  The results indicate 
that there was more cell proliferation in the AHR -/- ED 11.5 ovaries compared to the 
WT ED 11.5 ovaries as measured by a significantly higher volume ratio of nuclei in S 
phase of the cell cycle to total nuclei volume (Fig 21).  Additionally, there was a 
significantly higher ratio of germ cells in S phase of the cell cycle to total germ cell 
number in AHR -/- ED 11.5 ovaries compared to WT ED 11.5 ovaries (Fig 22 B).        
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Effect of AHR deletion on germ cell number in the embryonic ovary 
It was previously shown that  AHR -/- and WT embryonic ovaries after ED 13.5 
contain similar numbers of germ cells, but AHR -/- germ cells seem more resistant to 
cell death, and AHR -/- mice establish their primordial follicle pool earlier than WT mice 
(Benedict et al., 2000; Robles et al., 2000).  Thus, because most of the germ cell 
proliferation occurs before ED 13.5, we hypothesized that the AHR is involved in 
regulating the number of germ cells prior to entry into meiosis (Benedict et al., 2000; 
Robles et al., 2000).  To test this hypothesis, ED 11.5 fetal ovaries from AHR -/- and WT 
embryos were removed from pregnant dams as described above.  Germ cells were 
labeled with GCNA1 and nuclei were labeled with Hoescht.  The total number of germ 
cells per ovary were estimated and compared between AHR-/- and WT ED 11.5 
ovaries.  There were no significant differences in the number of germ cells per ovary 
between AHR -/- and WT ED 11.5 ovaries (Fig 22 A).     
 
6.5 Discussion 
 In recent years it has become evident that environmental ligands of the AHR 
cause germ cell death and reduce numbers of somatic cells in the embryonic ovary 
(Kee et al., 2010; Lutterodt et al., 2009; Matikainen et al., 2001).  The proper ratio of 
both ovarian cell types predicts the size and reproductive capacity of the follicular 
reserve, a predictor of female fertility (Bendsen et al., 2006).  Although environmental 
ligands of the AHR cause germ cell death, disrupted meiosis, and decreased number of 
somatic cells in the embryonic ovary leading to reduced fertility during adult life,  it is 
unclear what role the AHR plays under normal physiological conditions in the embryonic 
and neonatal ovary (Ge et al., 2012; Jurisicova et al., 2007; Matikainen et al., 2001).  
Interestingly, it was reported that systemic expression of the AHR changes with age; is 
more highly expressed during embryonic development and diminishes with increasing 
age (Petersen et al., 2006).  In this study, we did not find differences in AHR protein 
expression in the ovary from ED 13.5 to PND8 by western blot.  This suggests that the 
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AHR is present and plays an important role throughout the crucial period of PGC 
development, all the way to primordial follicle assembly. 
 One criterion for primordial follicle assembly is oocyte nest breakdown.  
Interestingly, we found evidence that the oocyte nests may be breaking apart faster in 
the AHR -/- ovaries compared to WT ovaries between PND 2 – 8.  We observed a 
significant reduction in the number of nests between PND 2 – 8 in the AHR -/- ovaries 
that was not evident in the WT ovaries.  We are not sure why the AHR -/- ovaries 
contained significantly more nests of the same size on PND 2 when compared to the 
WT mice because AHR -/- and WT embryonic ovaries contain similar numbers of germ 
cells before ED 18 (Benedict et al., 2000; Robles et al., 2000).  It is possible that more 
germ cells resist cell death between ED 18 and PND 2 in the AHR -/- ovaries compared 
to the WT ovaries.  This agrees with the studies reported by Robles et al. showing that 
AHR -/- ED 13.5 germ cells are more resistant to cell death compared to WT germ cells 
in an ovarian culture system (Robles et al., 2000).  This could lead to a more rapid 
formation of the primordial follicle pool postnatally, leaving extra germ cells unable to 
form primordial follicles.  The extra germ cells may not be able to assemble into 
primordial follicles because the ratio of germ cells to somatic cells are off balance in the 
AHR -/- ovary.  This would lead to rapid apoptosis of the additional oocytes not formed 
into primordial follicles, giving one possible mechanism for why AHR -/- ovaries 
contained significantly fewer germ cells not assembled into primordial follicles at PND 2 
and why AHR -/- and WT ovaries contained similar numbers of primordial follicles by 
PND 8 (Benedict et al., 2000).  It is possible that the AHR plays a dual role in germ cells 
and somatic cells of the developing ovary.  While it regulates cell death in the germ 
cells, it could also regulate proliferation/survival in the somatic cells controlling the 
number of somatic cells available to surround oocytes during primordial follicle 
assembly.  The advancement of  primordial follicle pool formation in the AHR -/- ovary 
does not translate into advanced development into primary follicles since AHR -/- and 
WT mice have similar numbers of primary follicles between PND 2 – PND 53, 
supporting the hypothesis that the AHR regulates germ cell death and somatic cell 
proliferation/survival during follicle assembly, and not later (Benedict JC et al., 2000).   
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 The major working hypothesis for cell death and survival in the embryonic and 
neonatal ovary is that germ cells and somatic cells depend on the availability of certain 
growth factors for survival or proliferation.  It could be that dependence on growth 
factors is a way of matching the number of oocytes to the number of somatic cells 
(Krysko et al., 2008).  In this case, a defined ratio of ovarian cell types and close 
communication between them would be required for normal development.  In support of 
this hypothesis, factors expressed in the surrounding ovarian somatic cells, such as 
tumor necrosis factor alpha (TNF), leukemia inhibitory factor (LIF), kit ligand (KITL), and 
interleukin 4 (IL4) have been shown to influence survival and proliferation of primordial 
germ cells (Krysko et al., 2008).  For example, mutant mice for KITL are infertile due to 
apoptosis of primordial germ cells (Choi and Rajkovic 2006; Krysko et al., 2008).  
Additionally, a neurotropin expressed in the mesenchymal cells of the developing ovary, 
nerve growth factor (NGF), has been identified as a regulator of primordial follicle 
assembly (Choi and Rajkovic 2006).  The neonatal ovaries of mice lacking NGF contain 
an increased number of oocytes that fail to be assembled into follicles (Dissen et al., 
2001).  Also, a transcription factor expressed in the female germ cells, folliculogenesis 
specific basic helix-loop-helix (FIGLA), has been shown to be essential for the survival 
of the developing oocyte and primordial follicle assembly (Joshi et al., 2007; Choi and 
Rajkovic 2006; Soyal et al., 2000).  Female mice lacking FIGLA are unable to form 
primordial follicles (Dean 2002).  Other oocyte specific factors such as growth and 
differentiation factor 9 (Gdf9) and bone morphogenetic protein 15 (Bmp15) have been 
shown to act on granulosa cells to modify their proliferation and directly affect follicle 
assembly (Edwards et al., 2008).  Mice lacking Gdf9 and Bmp15 have delayed 
primordial follicle formation (Carabatsos et al., 1998; Choi and Rajkovic 2006; 
Shimasaki et al., 2003; Zheng and Dean 2007). Collectively, these studies provide 
strong evidence that both oocyte and somatic cell specific factors are necessary for a 
two way dialogue that drives follicle formation.            
Interestingly, ovaries lacking the AHR have differential expression of genes with 
known function in cell death, proliferation, and meiosis during germ cell nest breakdown 
and follicle assembly as identified by gene microarray studies.  Among the genes 
identified from the array experiments, we identified two factors affected by AHR deletion 
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on PND2.  A gene necessary for maintaining spindle structure and proper movement of 
chromosomes during the cell cycle, kinesin family member 11 (Kif11), was significantly 
increased by 2 fold in the AHR -/- ovaries compared to the WT ovaries.  KIF11 is a 
microtubule motor protein with known functions in cell cycle, cell death, and meiosis.  
More specifically, previous studies have shown that it regulates bipolar spindle 
formation during mitosis and meiosis and aids in chromosome segregation (Mailhes et 
al., 2004; Sarli and Giannis 2008).  Kif11 over-expression disrupts the unique balance of 
forces associated with normal spindle assembly and function, and thereby leads to the 
development of spindle defects and genetic instability (Castillo et al., 2007).  We 
potentially identified one functional AHR response element (AHRE) within the Kif11 
promoter using chromatin immunoprecipitation methods (data not shown).  Thus, it is 
possible that the AHR regulates transcription of Kif11 and maintains stability of the 
mitotic and/or meiotic spindle in the ovary. 
The other gene, a gene essential for initiation of X chromosome inactivation, 
inactive X specific transcripts (Xist), was decreased by 2 fold in the AHR -/- ovary 
compared to the WT ovary.  Mammals compensate for different doses of X-
chromosome-linked genes in male (XY) and female (XX) somatic cells by terminally 
inactivating all, but one X chromosome in each cell during embryogenesis (Brockdorff 
2011; Goto and Monk 1998; Payer and Lee 2008).  Thus, after birth the Xist transcript 
should be active in the female somatic cells to maintain an inactive X-chromosome 
there.  On the other hand, in female germ cells, Xist expression ceases at around ED 
12.5 to 13.5 when the oocyte enters meiosis and the inactive X chromosome is 
reactivated (Goto and Monk 1998; Payer and Lee 2008).  This process insures that all 
of the oocytes inherit an active X to pass on to the next generation.  Thus, a decrease in 
the Xist transcripts in the AHR -/- PND 2 ovary could indicate two things.  Firstly, the 
decreased Xist levels could be due to the possibility that the AHR regulates survival of 
oocytes between ED 18 and PND2 which would change the levels of Xist transcripts in 
the whole ovary due to a higher ratio of meiotic oocytes to somatic cells.  Secondly, it 
could be an indication that the AHR is involved in regulating X-chromosome inactivation 
in ovarian somatic cells, and the silencing of X-chromosome linked genes is incomplete 
in the somatic cells of the AHR -/- ovary.  This could result in an over expression of 
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some X-linked genes in the AHR -/- ovary and instability of the genome.  The non-
coding Xist transcript causes X-chromosome silencing by coating the X chromosome in 
cis.  Xist can then recruit enzyme complexes that mediate histone modifications that 
further promote silencing of the X-chromosome.  It has been suggested that Xist itself is 
regulated by the methylation of its promoter and of the 5’ end of exon 1 of the Xist gene 
(Goto and Monk 1998).  Thus, it is possible that the AHR is also involved in epigenetic 
control of the Xist transcript in the ovary as was shown with the latent TGFβ-binding 
protein 1 (Ltbp-1) gene in mouse embryonic fibroblasts (MEFs).  Specifically, it was 
shown in MEFs that repression of Ltbp-1, which is a key regulator of TGFβ targeting 
and activation in the extracellular matrix, is due to epigenetics that requires the AHR 
(Gomez-Duran et al., 2008).   
   During the earliest stages of embryonic ovarian development, the ovary 
contains fewer germ cells compared to somatic cells which rapidly changes as 
embryonic development progresses, possibly due to rapid germ cell colonization and 
proliferation (Bendsen et al., 2006).  Interestingly, cigarette exposure during the earliest 
stages of human ovarian development leads to a significantly reduced number of 
somatic cells in the exposed embryonic ovary compared to the unexposed embryonic 
ovary (Lutterodt et al., 2009).  Cigarette smoke contains known ligands of the AHR.  
Thus, it is possible that the AHR regulates proliferation of the somatic cells in the 
embryonic ovary, which would assure that the growth factors necessary for germ cell 
development are sufficient.  The proper ratio of germ cells to somatic cells would then 
guarantee timely progression of the germ cells through meiosis I and primordial follicle 
assembly.  
Interestingly, the total number of primordial germ cells (PGCs) in the ED 11.5 
ovary was not affected by AHR deletion, but the ratio of actively proliferating PGCs was 
affected.  This suggests that PGC colonization may not be regulated by the AHR, but 
that the AHR may regulate primordial germ cell proliferation and may regulate the timing 
of meiotic entry.  Other factors recently identified that increase PGC proliferation and 
inhibit meiotic entry include basic fibroblast growth factor (bFGF), kit oncogene (c-kit), 
and Activin  (He et al., 2012; Manova and Bachvarova 1991; Martins da Silva et al., 
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2004; Tisdall et al., 1999).  Specifically, the kit oncogene (c-kit) is expressed in 
proliferating PGCs and its expression temporarily ceases in the early stages of meiosis 
(Manova and Bachvarova 1991; Tisdall et al., 1999).  Interestingly, AHR -/- mice lack c-
kit expression in their dendritic epidermal T cells in the skin (Kadow et al., 2011).  
Kadow et al. demonstrated that the AHR directly regulates c-kit in these cells.  Thus, it 
is possible that the AHR could regulate c-kit in the embryonic ovary as well, altering the 
dynamics of PGC proliferation.  Other factors that promote initiation of meiosis in the 
developing germ line such as R-spondin homolog (RSPO1) have been identified as well 
(Chassot et al., 2011).  Interestingly, it was shown that the AHR may regulate RSPO1 in 
embryonic neural crest cells (Sanbe et al., 2009).  An inhibition of RSPO1 could 
increase the period of PGC proliferation by delaying meiotic entry in the embryonic 
ovary.  
In summary, the AHR is expressed in the mouse ovary during the critical periods 
of meiotic maturation and primordial follicle assembly, solidifying its importance in 
ovarian development.  The dynamics of germ cell nest breakdown are altered leading to 
an earlier formation of the primordial follicle pool in the AHR -/- ovary compared to the 
WT ovary, indicating involvement of the AHR in this process.  It is possible that in 
ovaries lacking the AHR, oocyte survival is promoted over death and somatic cell 
dynamics are altered before PND2, altering the process of germ cell nest breakdown.   
This suggests a dual role for the AHR in oocytes and somatic cells of the developing 
ovary.  While the AHR may regulate cell death in the oocytes, it may regulate 
proliferation in the somatic cells.  This hypothesis is further supported by the increased 
proliferation in the ED 11.5 AHR -/- ovary, mainly due to proliferation of the somatic cells 
at this stage of development.  Also, because there were more PGCs proliferating in the 
AHR -/- ED 11.5 ovaries compared to the WT ED 11.5 ovaries, this suggests that the 
AHR may be important for regulating the period of PGC proliferation, and thus the 
timing of meiotic entry in the developing germ line.  Finally, the altered levels of Xist and 
Kif11 transcripts in the PND2 AHR -/- ovaries could indicate that the AHR may have 
functions involving X-chromosome inactivation and in maintaining mitotic and/or meiotic 
spindle stability in the neonatal ovary.  In conclusion, because fetuses and neonates are 
exposed to numerous environmental AHR ligands, further studies are needed to better 
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characterize the endogenous functions of the AHR in the ovary during the critical stages 
of development. 
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Diagram 1 
Schematic of development of the primordial follicle pool in mice.  Blue colored 
cells indicate somatic cells, green colored cells indicate germ cells, and black cells 
represent apoptotic germ cells.  Purple bars represent the range of meiotic progression 
for each meiotic stage.  Numbers indicate age of the embryos or pups.  PND = postnatal 
day; ED =embryonic day. 
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6.6 Figures 
Age: PND2 PND8 
Biological 
Process 
    
Proliferation ↑Tgfbr2, ↑Spn, ↑Cd24a ↑Tgfb1, ↑Cdh5, ↑Lhx9, ↑Csf1, 
↑Hoxa3, ↑Shc1, ↑Cxcr4, ↑Eif2ak1, 
↑Hipk2,↑Ticam1,   ↑Fgfr1, ↑Lamb1-
1, ↑Rasip1, ↑Numbl, ↑Ppard, ↑Icosl, 
↑Axin2, ↑E2f4, ↓Purb, ↓Appl1, 
↓Pten, ↓Cnbp, ↓Evi1, ↓Gtpbp4, 
↓Hdgfrp3, ↓Cd24a, ↓Calcrl, ↓Rps21, 
↓Gsk3b         
Cell Death ↑Myb, ↑Kif11, ↑Lgals7, ↑Tubb2b, 
↑Rbbp4, ↑Kifc1, ↑Ccnb1, ↑Hif1a, 
↑Spag5, ↑Cd24a, ↑Spn, ↑Mapk14, 
↓Cln8  
↓Fadd, ↓Rad21, ↑Tgfb1, ↑Ticam1, 
↑Rhob, ↑Fgfr1, ↓Gsk3b, ↑Hipk2, 
↑Ngfr, ↑Purb, ↑Cdh1, ↑Shank3, 
↑Bak1, ↑Ppard, ↑Pcbp4, ↓Pten, 
↑Pglyrp1, ↓Cd24a, ↑Bcl2l1, ↓Prune2, 
↑Elmo1           
Meiosis ↑Rad18, ↑Kifc1, ↑Kif11, ↑Eif2s3x ↓Rsph1, ↓Meig1, ↓Cenpe, ↓Dynlrb2, 
↓Kif5b, ↑Ehmt2, ↑Mad1l1, ↑Dazap1, 
↓Eif2a, ↓Eif3eip, ↑Eif2ak1, 
↑Eif4ebp2, ↑Igfbp4, ↑Igfbp5, ↑Stra6, 
↓Rad21, ↓Anapc11, ↑Xmr protein/ 
similar to Sycp3 like X-linked         
Note: Arrows indicate a ≥ 2 fold increase or decrease in transcript expression levels in 
the AHR -/- ovaries compared to WT ovaries at the developmental stage indicated. 
Table 3 
Differential gene expression in AHR -/- versus WT neonatal ovaries.  Ovaries from 
PND 2 and 8 AHR -/- and WT mice were isolated and immediately snap frozen in liquid 
nitrogen and stored at -80ºC until RNA extraction.  An equal amount of RNA from 6 
animals (12 ovaries) in each of the four groups was pooled, amplified, labeled, and 
subjected to Affymetrix GeneChip® 430 2.0 Mouse Genome arrays to compare the 
expression of more than 20,000 genes.  The differentially expressed Affymetrix tags that 
showed an increased or decreased signal of two fold or higher when compared to the 
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control (WT) were mapped to known genes and those genes were compiled into two 
lists (PND2 AHR -/- versus WT and PND8 AHR -/- versus WT).  The genes listed in the 
table represent differentially expressed genes that were categorized by whether they 
were involved in the biological process of proliferation, cell death, or meiosis. 
Table 4 
Tran
script 
NCBI 
reference 
sequence Forward primer sequence 5’- 3’ Reverse primer sequence 5’- 3’ 
Gapdh NM_008084.2 GTG CAG TGC CAG CCT CGT CC GCC ACT GCA AAT GGC AGC CC 
Ccnb1 NM_172301.3 AGT GAG TGA CGT AGA CGC AGA TGA TGT TTC CAG TCA CTT CAC GAC CCT 
Tgbr2 NM_009371.3 TAC CAC GGC TTC ACT CTG GAA GAT AAT GAC CAA CAA CAG GTC GGG ACT 
Hspa9 NM_010481.2 GTG CAG ACT GAC ATC AAC TTG CCA TCC TGC ATA GCT TTC TGA CAC GGA 
Nr2c2 NM_011630.3 ACT GCA TCA TCA ACA AGC ACC ACC AGC ACA ATT GCT TGG TTT CTC CCG 
Kif11 NM_010615.1 CCC TGC ATC TTT CAA TCT TGA GG CCC TGC ATC TTT CAA TCT TGA GGA AAC TC 
Xist NR_001463.3 TGC TTG AAC TAC TGC TCC TCC GTT GGA TTG TTT GTC CCT TTG GGC TCT 
Cxcr4 NM_009911.3 AGC AGG TAG CAG TGA AAC CTC TGA AGC AGG GTT CCT TGT TGG AGT CAT 
Bcl2l1 NM_009743.4 AAG CGT AGA CAA GGA GAT GCA GGT CTG CTG CAT TGT TCC CGT AGA GAT 
Csf1 NM_007778.4 TAC AAG TGG AAG TGG AGG AGC CAT AGT CCT GTG TGC CCA GCA TAG AAT 
Amh NM_007445.2 ACA GCT ATG AGT ATG CCT TCC TGG GAG GCT CTT GGA ACT TCA GCA AGA 
 
Primer pairs used for qPCR validation of the genes identified by the Affymetrix 
GeneChip® 430 2.0 Mouse Genome arrays. 
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Fig 17 
Levels of the AHR protein in the ovary during embryonic and neonatal 
development.  To determine if the AHR is present and/or changes expression levels 
during ovarian development, ovaries at various stages of development were isolated 
and assayed by western blot for AHR protein levels.  Embryonic day 13.5 (lanes 1 – 3) 
was chosen because female germ cells are initiating meiosis, embryonic day 15.5 
(lanes 4 – 6) was chosen because this is when female germ cells are arresting meiosis, 
postnatal day (PND) 2 (lanes 7 – 9) was chosen because this is when germ cell attrition 
peaks and primordial follicles are assembling, and PND 8 (lanes 10 – 12) was chosen 
because this is when the primordial follicle reserve is almost established in the 
developing mouse ovary.  Each bar in graph A represents the relative expression level ± 
SEM (n=3 ovaries per developmental stage).  Figure B are images of the protein bands 
for AHR and ACTB (lane 13 = blank and lane 14 = mouse liver). 
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Fig 18 
Histological evaluation of germ cell nest breakdown.  Ovaries were collected from 
AHR -/- and WT mice on PNDs 2 and 8 and subjected to histological evaluation for the 
number of germ cell nests per ovary and the  number of germ cells per nest.  The top 
two graphs (A & B) contain data from WT ovaries and the bottom two graphs (C & D) 
contain data from the AHR -/- ovaries.  Each bar represents the mean ± SEM (n= at 
least 4 animals per genotype, ** denotes p≤0.01 for PND 2 vs. PND8). 
WT nest # 
AHR -/- nest # 
WT nest size 
AHR -/- nest size 
B A 
C D 
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Fig 19 
Effect of AHR deletion on gene expression during primordial follicle assembly in 
the neonatal ovary.  To validate the array results, total RNA from the same PND 2 and 
8 ovaries used in the array experiment was analyzed by qPCR for genes selected 
based on their involvement in the biological process of proliferation, cell death, or 
meiosis.  The data are reported as the mean % maximum expression level relative to 
Gapdh ± SEM (n= 4-5 animals per group, * p≤0.05).   
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Fig 20 
Digital images of WT and AHR -/- ED 11.5 ovaries before and after three-
dimensional rendering. A single optical plane of all three channels merged 
(GCNA1=green, EdU=red, and Hoescht=blue) from two z stack images (Fig A = WT, D 
= AHR -/-, * = proliferating germ cell, # = proliferating somatic cell, a = germ cell not 
proliferating, + = somatic cell not proliferating, and white bar = 8 μm). Representative 
images of raw deconvoluted 3D rendered images from single ovarian fractions (B = WT 
and E = AHR -/-; white bar = 10 μm).  Representative images of 3D rendered volume 
isosurfaces used for quantification of EdU and Hoescht positive staining from single 
ovarian fractions (C = WT and F = AHR -/-; white bar = 10 μm).  
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Fig 21 
Effect of AHR deletion on cell proliferation in the embryonic ovary.  Pregnant dams 
from heterozygote matings were injected with EdU on embryonic day 11.5.  Embryonic 
ovaries were collected 6 hours later and processed for 2 dimensional fluorescent 
microscopy imaging and quantification.  The volume ratios of cells in S phase of the cell 
cycle to total cell volume between WT and AHR-/- embryonic 11.5 ovaries were 
compared.  ED 11.5 was chosen because this is one day after initial primordial germ 
cell colonization and both germ cells and somatic cells are rapidly dividing in the ovary.  
Each bar represents the mean volume ratio ± SEM (n=3 WT ovaries, n=2 AHR -/- 
ovaries; two fractions were imaged and analyzed for each group). 
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Fig 22 
Effect of AHR deletion on total germ cell number and germ cell proliferation in the 
embryonic ovary.  Pregnant dams from heterozygote matings were injected with EdU 
on embryonic day 11.5.  Embryonic ovaries were collected 6 hours later and processed 
for fluorescent microscopy imaging and quantification of total germ cell number (A) and 
ratio of germ cells in S phase of the cell cycle (B).  The data are presented as the mean 
germ cell number per ovary (n=3) (A) or the mean ratio of proliferating germ cells per 
ovary (n=2) (B).      
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